2021
Trevisan M, Fu EL, Xu Y, Jager KJ, Zoccali C, Dekker FW, Carrero JJ.Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design Clin Kidney J. 2021 May; 14(5):1307–1316.
Pippias M, Stel VS, Arnol M, Bemelman F, Berger SP, Ponikvar JB, Kramar R, Magaz Á, Nordio M, Peters-Sengers H, Reisæter AV, Sørensen SS, Massy ZA, Jager KJ.Temporal Trends in the Quality of Deceased Donor Kidneys and Kidney Transplant Outcomes in Europe: an analysis by the ERA-EDTA Registry.Nephrol Dial Transplant. 2021 Apr 12 [Epub ahead of print].
Boehm M, Bonthuis M, Aufricht C, Battelino N, Bjerre A, Edvardsson VO, Herthelius M, Hubmann H, Jahnukainen T, de Jong H, Laube GF, Mattozzi F, Molchanova EA, Muñoz M, Noyan A, Pape L, Printza N, Reusz G, Roussey G, Rubik J, Spasojević-Dimitrijeva B, Seeman T, Ware N, Vidal E, Harambat J, Jager KJ, Groothoff J.Kidney Transplantation in Small Children: Association Between Body Weight and Outcome – A Report From the ESPN/ERA-EDTA Registry.Transplantation. 2021 Mar 26. [Epub ahead of print].
de Jong RW, Jager KJ, Vanholder RC, Couchoud C, Murphy M, Rahmel A, Massy ZA, Stel VS.Erratum to: Results of the European EDITH Nephrologist survey on factors influencing treatment modality choice for end-stage kidney disease.Nephrol Dial Transplant. 2021 Mar 31. [Epub ahead of print].
Stel VS, Chesnaye NC, Tripepi G, Dekker FW, Zoccali C, Jager KJ.Points of attention when conducting etiological research.Nephrology (Carlton). 2021 Mar 17. [Epub ahead of print].
Ramspek CL, Evans M, Wanner C, Drechsler C, Chesnaye NC, Szymczak M, Krajewska M, Torino C, Porto G, Hayward S, Caskey F, Dekker FW, Jager KJ, van Diepen M; EQUAL Study Investigators.Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD.J. Am Soc Nephrol. 2021 Mar 8, [Epub ahead of print].
de Jong RW, Stel VS, Rahmel A, Murphy M, Vanholder RC, Massy ZA, Jager KJ.Patient-reported factors influencing the choice of their kidney replacement treatment modality.Nephrol Dial Transplant. 2021 Mar 2. [Epub ahead of print].
Cho Y, Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE, Bellorin-Font E, Gharbi MB, Davison SN, Ghnaimat M, Harden P, Htay H, Jha V, Kalantar-Zadeh K, Kerr PG, Klarenbach S, Kovesdy CP, Luyckx V, Neuen B, O’Donoghue D, Ossareh S, Perl J, Rashid HU, Rondeau E, See EJ, Saad S, Sola L, Tchokhonelidze I, Tesar V, Tungsanga K, Kazancioglu RT, Yee-Moon Wang A, Yang CW, Zemchenkov A, Zhao MH, Jager KJ, Caskey FJ, Jindal KK, Okpechi IG, Tonelli M, Harris DC, Johnson DW.Peritoneal Dialysis Use and Practice Patterns: An International Survey Study.Am J Kidney Dis. 2021 Mar;77(3):315-325.
Hellemans R, Kramer A, De Meester J, Collart F, Kuypers D, Jadoul M, Van Laecke S, Le Moine A, Krzesinski JM, Wissing KM, Luyckx K, Van Meel M, De Vries E, Tieken I, Vogelaar S, Samuel U, Abramowicz D, Stel VS, Jager KJ.Does kidney transplantation with a standard or expanded criteria donor improve patient survival?Nephrol Dial Transplant. 2021 Feb 26. [Epub ahead of print].
Roumeliotis S, Abd ElHafeez S, Jager KJ, Dekker FW, Stel VS, Pitino A, Zoccali C, Tripepi G.Be careful with ecological associations.Nephrology (Carlton). 2021 Feb 11. [Epub ahead of print].
van der Willik EM , van Zwet EW , Hoekstra T , van Ittersum FJ , Hemmelder MH , Zoccali C , Jager KJ , Dekker FW, Meuleman Y.Funnel plots of patient-reported outcomes to evaluate health-care quality: Basic principles, pitfalls and considerations.Nephrology (Carlton) 2021 Feb; 26(2):95-104.
Ploos van Amstel S, Noordzij M, Borzych-Duzalka D, Chesnaye NC, Xu H, Rees L, Ha IS, Antonio ZL, Hooman N, Wong W, Vondrak K, Yap YC, Patel H, Szczepanska M, Testa S, Galanti M, Kari JA, Samaille C, Bakkaloglu SA, Lai WM, Rojas LF, Diaz MS, Basu B, Neu A, Warady BA, Jager KJ, Schaefer F.Mortality in Children Treated With Maintenance Peritoneal Dialysis: Findings From the International Pediatric Peritoneal Dialysis Network Registry.Am J Kidney Dis. 2021 Feb 4:S0272-6386(21)00059-7.
Helve J, Kramer A, Abad Diez JM, Aresté-Fosalba N, Arici M , Cases A, Collart F, Heaf J, De Meester J, Nordio M, Palsson R, Pobes A, Rydell H, Varberg Reisæter A, Massy ZA, Jager KJ, Finne P.Effect of comorbidities on survival in patients >80 years at onset of renal replacement therapy: data from the ERA-EDTA Registry.Nephrol Dial Transplant, 2021 Feb 4. [Epub ahead of print].
Noordzij M, Vart P, Duivenvoorden R, Franssen CFM, Hemmelder MH, Jager KJ, Hilbrands LB, Gansevoort RT.Pitfalls when comparing COVID-19-related outcomes across studies-lessons learnt from the ERACODA collaboration.Clin Kidney J. 2021 Feb 2;14(Suppl 1):i14-i20.
de Jong RW, Jager KJ, Vanholder RC, Couchoud C, Murphy M, Rahmel A, Massy ZA, Stel VS.Results of the European Effect of Differing Kidney Disease Treatment Modalities and Organ Donation and Transplantation Practices on Health Expenditure and Patient Outcomes nephrologist survey on factors influencing treatment modality choice for end-stage kidney disease.Nephrol Dial Transplant. 2021 Jan 22. [Epub ahead of print].
Rao A, MacNeill SJ, van de Luijtgaarden MWM, Chesnaye NC, Drechsler C, Wanner C, Torino C, Postorino M, Szymczak M, Evans M, Dekker FW, Jager KJ, Ben-Shlomo Y, Caskey FJ, EQUAL Study Investigators.Using datasets to ascertain the generalisability of clinical cohorts: the example of European QUALity Study on the treatment of advanced chronic kidney disease (EQUAL).Nephrol Dial Transplant, 2021 Jan 11. [Epub ahead of print].
Ramspek CL, Jager KJ, Dekker FW, Zoccali C, van Diepen M.External validation of prognostic models: what, why, how, when and where?Clin Kidney J. 2021 Jan; 14(1):49-58.
Abd ElHafeez S, Noordzij M, Kramer A, Bell S, Savoye E, Abad Diez JM, Lundgren T, Varberg Reisaeter A, Kerschbaum J, Santiuste de Pablos C, Ortiz F, Collart F, Palsson R, Arici M, Heaf JG, Massy ZA, Jager KJ.The association of living donor source with patient and graft survival among kidney transplant recipients in the ERA-EDTA Registry – a retrospective study.Transpl Int. 2021 Jan; 34(1):76-86.
Bonthuis M, Vidal E, Bjerre A, Aydoğ Ö, Baiko S, Garneata L, Guzzo I, Heaf JG, Jahnukainen T, Lilien M,Mallett T, Mirescu G, Mochanova EA, Nüsken E, Rascher K, Roussinov D, Szczepanska M, TsimaratoM, Varvara A, Verrina E, Veselinović B, Jager KJ, Harambat J.Ten-year trends in epidemiology and outcomes of pediatric kidney replacement therapy in Europe: data from the ESPN/ERA-EDTA Registry.Pediatr Nephrol 2021 Jan 22. [Epub ahead of print].
Karaboyas A, Port FK, Massy ZA, Locatelli F, Cases A, Nitta K, Liabeuf S, Jager KJ, Robinson BM.Long- Versus Short-Acting Erythropoiesis-Stimulating Agent Type and Mortality.Kidney Int Rep. 2021 Jan; 6(1): 214–218.
Lunney M, Bello AK, Levin A, Tam-Tham H, Thomas C, Osman MA, Ye F, Bellorin-Font E, Benghanem Gharbi M, Ghnaimat M, Htay H, Cho Y, Jha V, Ossareh S, Rondeau E, Sola L, Tchokhonelidze I, Tesar V, Tungsanga K, Kazancioglu RT, Wang AY, Yang CW, Zemchenkov A, Zhao MH, Jager KJ, Jindal KK, Okpechi IG, Brown EA, Brown M, Tonelli M, Harris DC, Johnson DW, Caskey FJ, Davison SN.Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide.CJASN January 2021, 16(1):79-87.
2020
Fu EL, van Diepen M, Xu Y, Trevisan M, Dekker FW, Zoccali C, Jager K, Carrero JJ.Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them.Clin Kidney J. 2020 Dec 14;14(5):1317-1326.
Jager KJ, Kramer A, Chesnaye NC, Couchoud C, Sánchez-Álvarez JE, Garneata L, Collart F, Hemmelder MH, Ambühl P, Kerschbaum J, Legeai C, Del Pino Y Pino MD, Mircescu G, Mazzoleni L, Hoekstra T, Winzeler R, Mayer G, Stel VS, Wanner C, Zoccali C, Massy ZA.Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.Kidney Int. 2020 Dec;98(6):1540-1548.
Sever MŞ, Jager KJ, Vanholder R, Stengel B, Harambat J, Finne P, Tesař V, Barbullushi M, Bumblytė IA, Zakharova E, Spasovski G, Resic H, Wiecek A, Blankestijn PJ, Bruchfeld A, Cozzolino M, Goumenos D, Soler MJ, Rychlík I, Stevens KI, Wanner C, Zoccali C, Massy ZA.A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community.Clin Kidney J. 2020 Dec 22;14(1):23-35.
Stel VS, de Jong RW, Kramer A, Andrusev AM, Baltar JM, Barbullushi M, Bell S, Castro de la Nuez P, Cernevskis H, Couchoud C, De Meester J, Eriksen BO, Garneata L, Golan E, Helve J, Hemmelder MH, Hommel K, Ioannou K, Jarraya F, Kantaria N, Kerschbaum J, Komissarov KS, Magaz Á, Mercadal L, Ots-Rosenberg M, Palsson R, Rahmel A, Rydell H, Savino M, Seyahi N, Slon Roblero MF, Stojceva-Taneva O, Van der Tol A, Vazelov ES, Ziginskiene E, Zurriaga O, Vanholder RC, Massy ZA, Jager KJ.Supplemented ERA-EDTA Registry data evaluated the frequency of dialysis, kidney transplantation and comprehensive conservative management for patients with kidney failure in Europe.Kidney Int. 2020 Dec 21; [Epub ahead of print].
See EJ, Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE, Bellorin-Font E, Benghanem Gharbi M, Davison S, Ghnaimat M, Harden P, Htay H, Jha V, Kalantar-Zadeh K, Kerr PG, Klarenbach S, Kovesdy CP, Luyckx V, Neuen B, O’Donoghue D, Ossareh S, Perl J, Rashid HU, Rondeau E, Syed S, Sola L, Tchokhonelidze I, Tesar V, Tungsanga K, Kazancioglu RT, Wang AY, Yang CW, Zemchenkov A, Zhao MH, Jager KJ, Caskey F, Perkovic V, Jindal KK, Okpechi IG, Tonelli M, Feehally J, Harris DC, Johnson DW.Availability, coverage, and scope of health information systems for kidney care across world countries and regions.Nephrol Dial Transplant. 2020 Dec 22. [Epub ahead of print].
van der Willik EM , Terwee CB, Bos WJW, Hemmelder MH , Jager KJ , Zoccali C , Dekker FW, Meuleman Y.Patient-reported outcome measures (PROMs): making sense of individual PROM scores and changes in PROM scores over time.Nephrology (Carlton). 2020 Dec 16. [Epub ahead of print].
Jakulj L, Kramer A, Åsberg A, de Meester J, Santiuste de Pablos C, Helve J, Hemmelder MH, Hertig A, Arici M, Bell S, Mercadal L, Diaz-Corte C, Palsson R, Benitez Sanchez M, Kerschbaum J, Collart F, Massy ZA, Jager KJ, Noordzij M.Recovery of kidney function in patients treated with maintenance dialysis-a report from the ERA-EDTA registry.Nephrol Dial Transplant. 2020 Dec 23. [Epub ahead of print].
Hilbrands LB, Duivenvoorden R, Vart P, Franssen CFM, Hemmelder MH, Jager KJ, Kieneker LM, Noordzij M, Pena MJ, Vries H, Arroyo D, Covic A, Crespo M, Goffin E, Islam M, Massy ZA, Montero N, Oliveira JP, Roca Muñoz A, Sanchez JE, Sridharan S, Winzeler R, Gansevoort RT; ERACODA Collaborators.COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration.Nephrol Dial Transplant. 2020 Nov 1;35(11):1973-1983.
Boenink R, Stel VS, Waldum-Grevbo BE, Collart F, Kerschbaum J, Heaf JG, de Meester J, Finne P, García-Marcos SA, Evans M, Ambühl PM, Arici M, Ayav C, Steenkamp R, Cases A, Traynor JP, Palsson R, Zoccali C, Massy ZA, Jager KJ, Kramer A.Data from the ERA-EDTA Registry were examined for trends in excess mortality in European adults on kidney replacement therapy.Kidney Int. 2020 Oct;98(4):999-1008.
Hole BD, Evans KM, Pyart R, Davids MR, Bedat CG, Hanafusa N, Harris DCH, Jager KJ, Jha V, Johansen KL, McDonald S, Masakane I, Rosa-Diez G, Saran R, Wetmore JB, Caskey FJ. International collaborative efforts to establish kidney health surveillance systems.Kidney Int. 2020 Oct;98(4):812-816.
Bosdriesz JR, Stel VS, van Diepen M, Meuleman Y, Dekker FW, Zoccali C, Jager KJ.Evidence-based medicine – When observational studies are better than randomized controlled trials. Nephrology (Carlton). 2020 Oct; 25(10):737-743.
Bakker EA, Zoccali C, Dekker FW, Eijsvogels TMH, Jager KJ.Assessing physical activity and function in patients with chronic kidney disease: a narrative review.Clin Kidney J. 2020 Sep 8;14(3):768-779.
Mallamaci F, Torino C, Sarafidis P, Ekart R, Loutradis C, Siamopoulos K, Del Giudice A, Aucella F, Morosetti M, Raptis V, Bikos A, Papagianni A, Balafa O, Pappas E, Tripepi R, Marino C, Tripepi G, Ferro C, Malyszko J, Dekker FW, Jager KJ, London GM, Zoccali C.Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study.J Hypertens. 2020 Sep;38(9):1849-1856.
Zoccali C, Vanholder R, Wagner CA, Anders HJ, Blankestijn PJ, Bruchfeld A, Capasso G, Cozzolino M, Dekker FW, Fliser D, Fouque D, Gansevoort RT, Goumenos D, Jager KJ, Massy ZA, Oostrom TAJ, Rychlık I, Soler MJ, Stevens K, Spasovski G, Wanner C.Funding kidney research as a public health priority: challenges and opportunities.Nephrol Dial Transplant, 2020 Sep 4; [Epub ahead of print].
Jassal SV, Larkina M, Jager KJ, Murtagh FEM, O’Hare AM, Hanafusa N, Morgenstern H, Port FK, McCullough K, Pisoni R, Tentori F, Perlman R, Swartz RD.International variation in dialysis discontinuation in patients with advanced kidney disease.CMAJ. 2020 Aug 31;192(35):E995-E1002.
Kramer A, Boenink R, Noordzij M, Bosdriesz JR, Stel VS, Beltrán P, Ruiz JC, Seyahi N, Comas Farnés J, Stendahl M, Garneata L, Winzeler R, Golan E, Lopot F, Korejwo G, Bonthuis M, Lassalle M, Slon Roblero MF, Kuzema V, Hommel K, Stojceva-Taneva O, Asberg A, Kramar R, Hemmelder MH, de Meester J, Vazelov E, Andrusev A, Castro de la Nuez P, Helve J, Komissarov K, Casula A, Magaz A, Santiuste de Pablos C, Bubić I, Traynor JP, Ioannou K, Idrizi A, Palsson R, des Grottes JM, Spustova V, Tolaj-Avdiu M, Jarraya F, Nordio M, Ziginskiene E, Massy ZA, Jager KJ. The ERA-EDTA Registry Annual Report 2017: a summary.Clin Kidney J. 2020 August; 13(4) 693-709.
Htay H, Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE, Bellorin-Font E, Gharbi MB, Davison SN, Ghnaimat M, Harden P, Jha V, Kalantar-Zadeh K, Kerr PG, Klarenbach S, Kovesdy CP, Luyckx VA, Neuen B, O’Donoghue D, Ossareh S, Perl J, Rashid HU, Rondeau E, See EJ, Saad S, Sola L, Tchokhonelidze I, Tesar V, Tungsanga K, Kazancioglu RT, Yee-Moon Wang A, Yang CW, Zemchenkov A, Zhao MH, Jager KJ, Caskey FJ, Perkovic V, Jindal KK, Okpechi IG, Tonelli M, Harris DC, Johnson DW.Hemodialysis Use and Practice Patterns: An International Survey Study.Am J Kidney Dis. 2020 Aug 13:S0272-6386(20)30888 [Epub ahead of print].
Bonthuis M, Cuperus L, Chesnaye NC, Akman S, Alonso Melgar A, Baiko S, Bouts AH, Boyer O, Dimitrova K, do Carmo C, Grenda R, Heaf J, Jahnukainen T, Jankauskiene A, Kaltenegger L, Kostic M, Marks SD, Mitsioni A, Novljan G, Palsson R, Parvex P, Podracka L, Bjerre A, Seeman T, Slavicek J, Szabo T, Tönshoff B, Torres DD, van Hoeck KI, Westphal Ladfors S, Harambat J, Groothoff JW, Jager KJ. Results in the ESPN/ERA-EDTA Registry suggest disparities in access to kidney transplantation but little variation in graft survival of children across Europe. Kidney Int. 2020 Aug;98(2):464-475.
Tripepi G, Chesnaye NC, Dekker FW, Zoccali C, Jager KJ.Intention to treat and per protocol analysis in clinical trials.Nephrology (Carlton). 2020 Jul;25(7):513-517.
Chesnaye NC, Dekker FW, Evans M, Caskey FJ, Torino C, Postorino M, Szymczak M, Ramspek CL, Drechsler C, Wanner C, Jager KJ.Renal function decline in older men and women with advanced chronic kidney disease-results from the EQUAL studyNephrol Dial Transplant. 2020 Jun 27. [Epub ahead of print].
van Oosten MJM, Logtenberg SJJ, Edens MA, Hemmelder MH, Jager KJ, Bilo HJG, Stel VS.Health claims databases used for kidney research around the world.Clin Kidney J. 2020 Jun 27;14(1):84-97.
Jager KJ, Tripepi G, Chesnaye NC, Dekker FW, Zoccali C, Stel VS.Where to look for the most frequent biases?Nephrology (Carlton). 2020 Jun;25(6):435-441.
Hayward S, Hole B, Denholm R, Duncan P, Morris JE, Fraser SDS, Payne RA, Roderick P, Chesnaye NC, Wanner C, Drechsler C, Postorino M, Porto G, Szymczak M, Evans M, Dekker FW, Jager KJ, Caskey FJ. International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study.Nephrol Dial Transplant 2020 Jun 16.[Epub ahead of print].
van der Tol A, Stel VS, Jager KJ, Lameire N, Morton RL, Van Biesen W, Vanholder R; European Kidney Health Alliance (EKHA).A call for harmonization of European kidney care: dialysis reimbursement and distribution of kidney replacement therapies.Nephrol Dial Transplant. 2020 Jun 1;35(6):979-986.
Jager KJ, Dekker FW, Zoccali C.A new series of advanced-level research methods papers.Clin Kidney J. 2020 Apr 8;13(2):142.
Chesnaye NC, Tripepi G, Dekker FW, Zoccali C, Zwinderman AH, Jager KJ.An introduction to joint models-applications in nephrology.Clin Kidney J. 2020 Apr 8;13(2):143-149.
Hole B, Hemmelgarn B, Brown E, Brown M, McCulloch MI, Zuniga C, Andreoli SP, Blake PG, Couchoud C, Cueto-Manzano AM, Dreyer G, Garcia Garcia G, Jager KJ, McKnight M, Morton RL, Murtagh FEM, Naicker S, Obrador GT, Perl J, Rahman M, Shah KD, Van Biesen W, Walker RC, Yeates K, Zemchenkov A, Zhao MH, Davies SJ, Caskey FJ.Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world.Kidney Int Suppl (2011). 2020 Mar;10(1):e86-e94.
Pecoits-Filho R, Okpechi IG, Donner JA, Harris DCH, Aljubori HM, Bello AK, Bellorin-Font E, Caskey FJ, Collins A, Cueto-Manzano AM, Feehally J, Goh BL, Jager KJ, Nangaku M, Rahman M, Sahay M, Saleh A, Sola L, Turan Kazancioglu R, Walker RC, Walker R, Yao Q, Yu X, Zhao MH, Johnson DW.Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes.Kidney Int Suppl (2011). 2020 Mar;10(1):e3-e9.
Jansz TT, Noordzij M, Kramer A, Laruelle E, Couchoud C, Collart F, Cases A, Arici M, Helve J, Waldum-Grevbo B, Rydell H, Traynor JP, Zoccali C, Massy ZA, Jager KJ, van Jaarsveld BC.Survival of patients treated with extended-hours haemodialysis in Europe: an analysis of the ERA-EDTA Registry.Nephrol Dial Transplant. 2020 Mar 1;35(3):488-495.
Pippias M, Jager KJ, Åsberg A, Berger SP, Finne P, Heaf JG, Kerschbaum J, Lempinen M, Magaz Á, Massy ZA, Stel VS.Young deceased donor kidneys show a survival benefit over older donor kidneys in transplant recipients ages 20-50 years: a study by the ERA-EDTA Registry.Nephrol Dial Transplant. 2020 Mar 1;35(3):534-543.
Rule AD, Jager KJ, van den Brand JAJG, Delanaye P.Authors’ ReplyJ Am Soc Nephrol. 2020 Feb;31(2):448-449.
Hellemans R, Jager KJ, Abramowicz D.Transplantation in older individuals: is it really better than dialysis?Curr Opin Organ Transplant. 2020 Feb;25(1):86-91.
Janmaat CJ, van Diepen M, Meuleman Y, Chesnaye NC, Drechsler C, Torino C, Wanner C, Postorino M, Szymczak M, Evans M, Caskey FJ, Jager KJ, Dekker FW; EQUAL Study Investigators.Kidney function and symptom development over time in elderly patients with advanced chronic kidney disease: results of the EQUAL cohort study.Nephrol Dial Transplant. 2020 Jan 14.[Epub ahead of print].
Bonthuis M, Groothoff JW, Ariceta G, Baiko S, Battelino N, Bjerre A, Cransberg K, Kolvek G, Maxwell H, Miteva P, Molchanova MS, Neuhaus TJ, Pape L, Reusz G, Rousset-Rouviere C, Sandes AR, Topaloglu R, Dyck MV, Ylinen E, Zagozdzon I, Jager KJ, Harambat J.Growth Patterns After Kidney Transplantation in European Children Over the Past 25 Years: An ESPN/ERA-EDTA Registry Study.Transplantation. 2020 Jan;104(1):137-144.
de Jong RW, Stel VS, Heaf JG, Murphy M, Massy ZA, Jager KJ.Non-medical barriers reported by nephrologists when providing renal replacement therapy or comprehensive conservative management to end-stage kidney disease patients: a systematic review.Nephrol Dial Transplant. 2020 Jan 3.[Epub ahead of print].
2019
Preka E, Bonthuis M, Harambat J, Jager KJ.Think Twice before Postponing Chronic Dialysis in Children.J Am Soc Nephrol. 2019 Dec;30(12):2473-2474.
Liabeuf S, Sajjad A, Kramer A, Bieber B, McCullough K, Pisoni R, Caskey F, Combe C, Robinson BM, Jager KJ, Massy ZA.Guideline attainment and morbidity/mortality rates in a large cohort of European haemodialysis patients (EURODOPPS).Nephrol Dial Transplant. 2019 Dec 1;34(12):2105-2110.
Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C.A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases.Nephrol Dial Transplant. 2019 Nov 1;34(11):1803-1805.
Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C.A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases.Kidney Int. 2019 Nov;96(5):1048-1050.
Chesnaye NC, Szummer K, Bárány P, Heimbürger O, Magin H, Almquist T, Uhlin F, Dekker FW, Wanner C, Jager KJ, Evans M; EQUAL Study Investigators.Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients.J Am Heart Assoc. 2019 Nov 5;8(21).
Antlanger M, Noordzij M, van de Luijtgaarden M, Carrero JJ, Palsson R, Finne P, Hemmelder MH, Aresté-Fosalba N, Reisæter AV, Cases A, Traynor JP, Kramar R, Massy Z, Jager KJ, Hecking M; ERA-EDTA Registry.Sex Differences in Kidney Replacement Therapy Initiation and Maintenance.Clin J Am Soc Nephrol. 2019 Nov 7;14(11):1616-1625.
Preka E, Bonthuis M, Harambat J, Jager KJ, Groothoff JW, Baiko S, Bayazit AK, Boehm M, Cvetkovic M, Edvardsson VO, Fomina S, Heaf JG, Holtta T, Kis E, Kolvek G, Koster-Kamphuis L, Molchanova EA, Munoz M, Neto G, Novljan G, Printza N, Sahpazova E, Sartz L, Sinha MD, Vidal E, Vondrak K, Vrillon I, Weber LT, Weitz M, Zagozdzon I, Stefanidis CJ, Bakkaloglu SA.Association between timing of dialysis initiation and clinical outcomes in the paediatric population: an ESPN/ERA-EDTA registry study.Nephrol Dial Transplant. 2019 Nov 1;34(11):1932-1940.
Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE, Bellorin-Font E, Benghanem Gharbi M, Davison SN, Ghnaimat M, Harden P, Htay H, Jha V, Kalantar-Zadeh K, Kerr PG, Klarenbach S, Kovesdy CP, Luyckx VA, Neuen BL, O’Donoghue D, Ossareh S, Perl J, Rashid HU, Rondeau E, See E, Saad S, Sola L, Tchokhonelidze I, Tesar V, Tungsanga K, Turan Kazancioglu R, Wang AY, Wiebe N, Yang CW, Zemchenkov A, Zhao MH, Jager KJ, Caskey F, Perkovic V, Jindal KK, Okpechi IG, Tonelli M, Feehally J, Harris DC, Johnson DW.Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey.BMJ. 2019 Oct 31;367:l5873.
Voskamp PWM, van Diepen M, Evans M, Caskey FJ, Torino C, Postorino M, Szymczak M, Klinger M, Wallquist C, van de Luijtgaarden MWM, Chesnaye NC, Wanner C, Jager KJ, Dekker FW.The impact of symptoms on health-related quality of life in elderly pre-dialysis patients: effect and importance in the EQUAL study.Nephrol Dial Transplant. 2019 Oct 1;34(10):1707-1715.
Fu EL, Groenwold RHH, Zoccali C, Jager KJ, van Diepen M, Dekker FW.Merits and caveats of propensity scores to adjust for confounding.Nephrol Dial Transplant. 2019 Oct 1;34(10):1629-1635.
Delanaye P, Jager KJ, Bökenkamp A, Christensson A, Dubourg L, Eriksen BO, Gaillard F, Gambaro G, van der Giet M, Glassock RJ, Indridason OS, van Londen M, Mariat C, Melsom T, Moranne O, Nordin G, Palsson R, Pottel H, Rule AD, Schaeffner E, Taal MW, White C, Grubb A, van den Brand JAJG.CKD: A Call for an Age-Adapted Definition.J Am Soc Nephrol. 2019 Oct;30(10):1785-1805.
Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD, Heaf JG, Hemmelder MH, Martínez-Castelao A, de Meester J, Palsson R, Prischl FC, Segelmark M, Traynor JP, Santamaria R, Reisaeter AV, Massy ZA, Jager KJ.International comparison of trends in patients commencing renal replacement therapy by primary renal disease.Nephrology (Carlton). 2019 Oct;24(10):1064-1076.
Sarafidis PA, Mallamaci F, Loutradis C, Ekart R, Torino C, Karpetas A, Raptis V, Bikos A, Papagianni A, Balafa O, Siamopoulos K, Pisani G, Morosetti M, Del Giudice A, Aucella F, Di Lullo L, Tripepi R, Tripepi G, Jager K, Dekker F, London G, Zoccali C.Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.Nephrol Dial Transplant. 2019 Sep 1;34(9):1542-1548.
Massy ZA, Caskey FJ, Finne P, Harambat J, Jager KJ, Nagler E, Stengel B, Sever MS, Vanholder R, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Soler MJ, Rychlík I, Spasovski G, Stevens K, Wanner C, Zoccali C.Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe.Nephrol Dial Transplant. 2019 Sep 1;34(9):1469-1480.
Fotheringham J, Sajjad A, Stel VS, McCullough K, Karaboyas A, Wilkie M, Bieber B, Robinson BM, Massy ZA, Jager KJ.The association between longer haemodialysis treatment times and hospitalization and mortality after the two-day break in individuals receiving three times a week haemodialysis.Nephrol Dial Transplant. 2019 Sep 1;34(9):1577-1584.
Drube J, Wan M, Bonthuis M, Wühl E, Bacchetta J, Santos F, Grenda R, Edefonti A, Harambat J, Shroff R, Tönshoff B, Haffner D, European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups.Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease.Nat Rev Nephrol. 2019 Sep;15(9):577-589.
Vanholder R, Stel VS, Jager KJ, Lameire N, Loud F, Oberbauer R, de Jong RW, Zoccali C.How to increase kidney transplant activity throughout Europe-an advocacy review by the European Kidney Health Alliance.Nephrol Dial Transplant. 2019 Aug 1;34(8):1254-1261.
Tantiyavarong P, Kramer A, Heaf JG, Finne P, Åsberg A, Cases A, Caskey FJ, Massy ZA, Jager KJ, Noordzij M.Changes in clinical indicators related to the transition from dialysis to kidney transplantation-data from the ERA-EDTA Registry. Clin Kidney J. 2019 Jul 1;13(2):188-198.
van de Luijtgaarden MWM, Caskey FJ, Wanner C, Chesnaye NC, Postorino M, Janmaat CJ, Rao A, Torino C, Klinger M, Drechsler C, Heimburger O, Szymczak M, Evans M, Dekker FW, Jager KJ; EQUAL study investigators .Uraemic symptom burden and clinical condition in women and men of ≥65 years of age with advanced chronic kidney disease: results from the EQUAL study.Nephrol Dial Transplant. 2019 Jul 1;34(7):1189-1196.
Noordzij M, Cornet R, Simpson K, Jager KJ, Tomson CRV.An update of the ERA-EDTA Registry primary renal disease coding system: what’s new?Nephrol Dial Transplant. 2019 Jun 1;34(6):896-898.
Kainz A, Berner C, Ristl R, Simon A, Stamm T, Zitt E, Kramar R, Antlanger M, Kautzky-Willer A, Schmaldienst S, Schernhammer E, Port FK, Carrero JJ, Jager KJ, Hecking M.Sex-specific analysis of haemodialysis prevalence, practices and mortality over time: the Austrian Dialysis Registry from 1965 to 2014.Nephrol Dial Transplant. 2019 Jun 1;34(6):1026-1035.
Janmaat CJ, van Diepen M, Tsonaka R, Jager KJ, Zoccali C, Dekker FW.Pitfalls of linear regression for estimating slopes over time and how to avoid them by using linear mixed-effects models.Nephrol Dial Transplant. 2019 Apr 1;34(4):561-566.
Boehm M, Bonthuis M, Noordzij M, Harambat J, Groothoff JW, Melgar ÁA, Buturovic J, Dusunsel R, Fila M, Jander A, Koster-Kamphuis L, Novljan G, Ortega PJ, Paglialonga F, Saravo MT, Stefanidis CJ, Aufricht C, Jager KJ, Schaefer F.Hemodialysis vascular access and subsequent transplantation: a report from the ESPN/ERA-EDTA Registry.Pediatr Nephrol. 2019 Apr;34(4):713-721.
Verberne WR, Das-Gupta Z, Allegretti AS, Bart HAJ, van Biesen W, García-García G, Gibbons E, Parra E, Hemmelder MH, Jager KJ, Ketteler M, Roberts C, Al Rohani M, Salt MJ, Stopper A, Terkivatan T, Tuttle KR, Yang CW, Wheeler DC, Bos WJW.Development of an International Standard Set of Value-Based Outcome Measures for Patients With Chronic Kidney Disease: A Report of the International Consortium for Health Outcomes Measurement (ICHOM) CKD Working Group.Am J Kidney Dis. 2019 Mar;73(3):372-384.
INTEGRATED group consists of (in alphabetical order), Chan C, Combes G, Davies S, Finkelstein F, Firanek C, Gomez R, Jager KJ, George VJ, Johnson DW, Lambie M, Madero M, Masakane I, McDonald S, Misra M, Mitra S, Moraes T, Nadeau-Fredette AC, Mukhopadhyay P, Perl J, Pisoni R, Robinson B, Ryu DR, Saran R, Sloand J, Sukul N, Tong A, Szeto CC, Van Biesen W.Transition Between Different Renal Replacement Modalities: Gaps in Knowledge and Care-The Integrated Research Initiative.Perit Dial Int. 2019 Jan-Feb;39(1):4-12.
Kramer A, Pippias M, Noordzij M, Stel VS, Andrusev AM, Aparicio-Madre MI, Arribas Monzón FE, Åsberg A, Barbullushi M, Beltrán P, Bonthuis M, Caskey FJ, Castro de la Nuez P, Cernevskis H, De Meester J, Finne P, Golan E, Heaf JG, Hemmelder MH, Ioannou K, Kantaria N, Komissarov K, Korejwo G, Kramar R, Lassalle M, Lopot F, Macário F, Mackinnon B, Pálsson R, Pechter Ü, Piñera VC, Santiuste de Pablos C, Segarra-Medrano A, Seyahi N, Slon Roblero MF, Stojceva-Taneva O, Vazelov E, Winzeler R, Ziginskiene E, Massy Z, Jager KJ.The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary.Clin Kidney J. 2019 Feb 26;12(5):702-720.
Hruskova Z, Pippias M, Stel VS, Abad-Díez JM, Benítez Sánchez M, Caskey FJ, Collart F, De Meester J, Finne P, Heaf JG, Magaz A, Palsson R, Reisæter AV, Salama AD, Segelmark M, Traynor JP, Massy ZA, Jager KJ, Tesar V.Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.Am J Kidney Dis. 2019 Feb;73(2):184-193.
2018
Bonthuis M, Harambat J, Bérard E, Cransberg K, Duzova A, Garneata L, Herthelius M, Lungu AC, Jahnukainen T, Kaltenegger L, Ariceta G, Maurer E, Palsson R, Sinha MD, Testa S, Groothoff JW, Jager KJ; on behalf of the ESPN/ERA-EDTA Registry.Recovery of Kidney Function in Children Treated with Maintenance Dialysis.Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1510-1516.
Hemke AC, Heemskerk MBA, van Diepen M, Kramer A, de Meester J, Heaf JG, Abad Diez JM, Torres Guinea M, Finne P, Brunet P, Vikse BE, Caskey FJ, Traynor JP, Massy ZA, Couchoud C, Groothoff JW, Nordio M, Jager KJ, Dekker FW, Hoitsma AJ.Performance of an easy-to-use prediction model for renal patient survival: an external validation study using data from the ERA-EDTA Registry.Nephrol Dial Transplant. 2018 Oct 1;33(10):1786-1793.
Ceretta ML, Noordzij M, Luxardo R, De Meester J, Abad Diez JM, Finne P, Heaf JG, Couchoud C, Kramar R, Collart F, Cases A, Palsson R, Reisæter AV, Rydell H, Massy ZA, Jager KJ, Kramer A.Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA Registry.Nephrol Dial Transplant. 2018 Oct 1;33(10):1794-1804.
Ocak G, Noordzij M, Rookmaaker MB, Cases A, Couchoud C, Heaf JG, Jarraya F, De Meester J, Groothoff JW, Waldum-Grevbo BE, Palsson R, Resic H, Remón C, Finne P, Stendahl M, Verhaar MC, Massy ZA, Dekker FW, Jager KJ.Mortality due to bleeding, myocardial infarction and stroke in dialysis patients.J Thromb Haemost. 2018 Oct;16(10):1953-1963.
Luxardo R, Kramer A, González-Bedat MC, Massy ZA, Jager KJ, Rosa-Diez G, Noordzij M and collaborators.The epidemiology of renal replacement therapy in two different parts of the world: the Latin American Dialysis and Transplant Registry versus the European Renal Association-European Dialysis and Transplant Association Registry.Rev Panam Saluda Publica. 2018 Sep7; 42:e87
Helve J, Kramer A, Abad-Diez JM, Couchoud C, de Arriba G, de Meester J, Evans M, Glaudet F, Grönhagen-Riska C, Heaf JG, Lezaic V, Nordio M, Palsson R, Pechter Ü, Resic H, Santamaria R, Santiuste de Pablos C, Massy ZA, Zurriaga Ó, Jager KJ, Finne P.Factors associating with differences in the incidence of renal replacement therapy among elderly: data from the ERA-EDTA Registry.Nephrol Dial Transplant. 2018 Aug 1;33(8):1428-1435.
Pippias M, Jager KJ, Caskey F, Casula A, Erlandsson H, Finne P, Heaf J, Heinze G, Hoitsma A, Kramar R, Lempinen M, Magaz A, Midtvedt K, Mumford LL, Pascual J, Prütz KG, Sørensen SS, Traynor JP, Massy ZA, Ravanan R, Stel VS.Kidney transplant outcomes from older deceased donors: A paired kidney analysis by the ERA-EDTA Registry.Transpl Int. 2018 Jul;31(7):708-719.
Brück K, Jager KJ, Zoccali C, Bello AK, Minutolo R, Ioannou K, Verbeke F, Völzke H, Arnlöv J, Leonardis D, Ferraro PM, Brenner H, Caplin B, Kalra PA, Wanner C, Castelao AM, Gorriz JL, Hallan S, Rothenbacher D, Gibertoni D, De Nicola L, Heinze G, Van Biesen W, Stel VS; European CKD Burden Consortium.Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.Kidney Int. 2018 Jun;93(6):1432-1441.
Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA, James MT, Heerspink HJL, Pollock CA, Stevens PE, Kurella Tamura M, Tonelli MA, Wheeler DC, Winkelmayer WC, Cheung M, Hemmelgarn BR for Conference Participants.Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018 Jun;93(6):1281-1292.
Pippias M, Stel VS, Kramer A, Abad Diez JM, Aresté-Fosalba N, Ayav C, Buturovic J, Caskey FJ, Collart F, Couchoud C, De Meester J, Heaf JG, Helanterä I, Hemmelder MH, Kostopoulou M, Noordzij M, Pascual J, Palsson R, Reisaeter AV, Traynor JP, Massy Z, Jager KJ.Access to kidney transplantation in European adults aged 75 to 84 years and related outcomes: An analysis of the ERA-EDTA Registry database.Transpl Int. 2018 May;31(5):540-553.
Windahl K, Faxén Irving G, Almquist T, Lidén MK, van de Luijtgaarden M, Chesnaye NC, Voskamp P, Stenvinkel P, Klinger M, Szymczak M, Torino C, Postorini M, Drechsler C, Caskey FJ, Wanner C, Dekker FW, Jager KJ, Evans M.Prevalence and Risk of Protein-Energy Wasting Assessed by Subjective Global Assessment in Older Adults With Advanced Chronic Kidney Disease: Results From the EQUAL Study.J Ren Nutr. 2018 May;28(3):165-174.
Ploos van Amstel S, Noordzij M, Warady BA, Cano F, Craig JC, Groothoff JW, Ishikura K, Neu A, Safouh H, Xu H, Jager KJ, Schaefer F.Renal replacement therapy for children throughout the world: the need for a global registry.Pediatr Nephrol. 2018 May;33(5):863-871.
Windahl K, Faxén Irving G, Almquist T, Lidén MK, van de Luijtgaarden M, Chesnaye NC, Voskamp P, Stenvinkel P, Klinger M, Szymczak M, Torino C, Postorini M, Drechsler C, Caskey FJ, Wanner C, Dekker FW, Jager KJ, Evans M.Prevalence and Risk of Protein-Energy Wasting Assessed by Subjective Global Assessment in Older Adults With Advanced Chronic Kidney Disease: Results From the EQUAL Study.J Ren Nutr. 2018 May;28(3):165-174.
Peters F, Westphal C, Kramer A, Westerman R. Is the Rise in the Prevalence of Renal Replacement Therapy at Older Ages the Price for Living Longer? Front Public Health. 2018 May 4;6:138.
Chesnaye NC, van Stralen KJ, Bonthuis M, Harambat J, Groothoff JW, Jager KJ.Survival in children requiring chronic renal replacement therapy.Pediatr Nephrol. 2018 Apr;33(4):585-594.
Groothoff JW, Offringa M, Grootenhuis M, Jager KJ.Long-term consequences of renal insufficiency in children: lessons learned from the Dutch LERIC study.Nephrol Dial Transplant.2018 Apr 1;33(4):552-560.
Jager KJ, Stel VS, Branger P, Guijt M, Busic M, Dragovic M, Diekmann F, Manyalich M, Di Ciaccio P, Nanni Costa A, Collett D, Mumford L, Haase B, Hemke A, Deme O, Mihály S, Murphy M, Couchoud C, Massy Z, Lingemann M, Rahmel A.The effect of differing kidney disease treatment modalities and organ donation and transplantation practices on health expenditure and patient outcomes.Nephrol Dial Transplant. 2018 Apr 1;33(4):560-562.
Van Stralen KJ, Verrina E, Belingheri M, Dudley J, Dusek J, Grenda R, Macher MA, Puretic Z, Rubic J, Rudaitis S, Rudin C, Schaefer F, Jager KJ.Corrigendum-ErrataNephrol Dial Transplant. 2018 Mar 1;33(3):542.
Carrero JJ, Hecking M, Chesnaye NC, Jager KJ.Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease.Nat Rev Nephrol. 2018 Mar;14(3):151-164.
Critselis E, Vlahou A, Stel VS, Morton RL.Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion.Nephrol Dial Transplant. 2018 Mar 1;33(3):441-449.
Duranton F, Kramer A, Szwarc I, Bieber B, Gayrard N, Jover B, Vetromile F, Massy ZA, Combe C, Tentori F, Jager KJ, Servel MF, Argilés À.Geographical Variations in Blood Pressure Level and Seasonality in Hemodialysis Patients.Hypertension. 2018 Feb;71(2):289-296.
Kramer A, Pippias M, Noordzij M, Stel VS, Afentakis N, Ambühl PM, Andrusev AM, Fuster EA, Arribas Monzón FE, Åsberg A, Barbullushi M, Bonthuis M, Caskey FJ, Castro de la Nuez P, Cernevskis H, des Grottes JM, Garneata L, Golan E, Hemmelder MH, Ioannou K, Jarraya F, Kolesnyk M, Komissarov K, Lassalle M, Macario F, Mahillo-Duran B, Martín de Francisco AL, Palsson R, Pechter Ü, Resic H, Rutkowski B, Santiuste de Pablos C, Seyahi N, Simic Ogrizovic S, Slon Roblero MF, Spustova V, Stojceva-Taneva O, Traynor J, Massy ZA, Jager KJ.The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary.Clin Kidney J. 2018 Feb;11(1):108-122.
Montini G, Busutti M, Yalcinkaya F, Woolf AS, Weber S; European Society for Paediatric Nephrology Working Group on Congenital Anomalies of the Kidney and Urinary Tract.A questionnaire survey of radiological diagnosis and management of renal dysplasia in children.J Nephrol. 2018 Feb;31(1):95-102
Vidal E, Chesnaye NC, Paglialonga F, Minale B, Leozappa G, Giordano M, Gianoglio B, Corrado C, Roperto RM, Chimenz R, Mencarelli F, Ratsch IM, Murer L, Verrina E; Italian Registry for Paediatric Chronic Dialysis.A propensity-matched comparison of hard outcomes on children on chronic dialysis.Eur J Pediatr. 2018 Jan;177(1):117-124.
Yalcinkaya F, Bonthuis M, Erdogan BD, van Stralen KJ, Baiko S, Chehade H, Maxwell H, Montini G, Rönnholm K, Sørensen SS, Ulinski T, Verrina E, Weber S, Harambat J, Schaefer F, Jager KJ, Groothoff JW.Outcomes of renal replacement therapy in boys with prune belly syndrome: findings from the ESPN/ERA-EDTA Registry.Pediatr Nephrol. 2018 Jan;33(1):117-124.
2017
Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy ZA, Wanner C, Anders JH.Chronic kidney disease.Nat Rev Dis Primers. 2017 Nov 23;3:17088.
Chesnaye NC, van Stralen KJ, Bonthuis M, Groothoff JW, Harambat J, Schaefer F, Canpolat N, Garnier A, Heaf J, de Jong H, Schwartz Sørensen S, Tönshoff B, Jager KJ.The association of donor and recipient age with graft survival in paediatric renal transplant recipients in a European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplantation Association Registry study.Nephrol Dial Transplant. 2017 Nov 1;32(11):1949-1956.
Tjaden LA, Jager KJ, Bonthuis M, Kuehni CE, Lilien MR, Seeman T, Stefanidis CJ, Tse Y, Harambat J, Groothoff JW, Noordzij M.Racial variation in cardiovascular disease risk factors among European children on renal replacement therapy-results from the European Society of Paediatric Nephrology/European Renal Association – European Dialysis and Transplant Association Registry.Nephrol Dial Transplant. 2017 Nov 1;32(11):1908-1917.
Liabeuf S, Van Stralen KJ, Caskey F, Tentori F, Pisoni RL, Sajjad A, Jager KJ, Massy ZA.Attainment of guideline targets in EURODOPPS haemodialysis patients: are differences related to a country’s healthcare expenditure and nephrologist workforce?Nephrol Dial Transplant. 2017 Oct 1;32(10):1737-1749.
Nistor I, Bolignano D, Haller MC, Nagler E, van der Veer SN, Jager K, Covic A, Webster A, Van Biesen W.Why creating standardized core outcome sets for chronic kidney disease will improve clinical practice.Nephrol Dial Transplant. 2017 Aug 1;32(8):1268-1273.
Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Fliser D, Fouque D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Parati G, Rossignol P, Wiecek A, London G; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association-European Dialysis Transplantation Association (ERA-EDTA).The systemic nature of CKD.Nat Rev Nephrol. 2017 Jun;13(6):344-358.
Chesnaye NC, Schaefer F, Bonthuis M, Holman R, Baiko S, Baskın E, Bjerre A, Cloarec S, Cornelissen EA, Espinosa L, Heaf J, Stone R, Shtiza D, Zagozdzon I, Harambat J, Jager KJ, Groothoff JW, van Stralen KJ; on behalf of the ESPN/ERA-EDTA Registry Committee.Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of end-stage renal disease across Europe: an ESPN-ERA/EDTA registry analysis.Lancet. 2017 May 27;389(10084):2128-2137.
Vidal E, van Stralen KJ, Chesnaye NC, Bonthuis M, Holmberg C, Zurowska A, Trivelli A, Da Silva JE, Herthelius M, Adams B, Bjerre A, Jankauskiene A, Miteva P, Emirova K, Bayazit AK, Mache CJ, Sánchez-Moreno A, Harambat J, Groothoff JW, Jager KJ, Schaefer F, Verrina E; ESPN/ERA-EDTA Registry.Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.Am J Kidney Dis. 2017 May;69(5):617-625.
Pippias M, Kramer A, Noordzij M, Afentakis N, Alonso de la Torre R, Ambühl PM, Aparicio Madre MI, Arribas Monzón F, Åsberg A, Bonthuis M, Bouzas Caamaño E, Bubic I, Caskey FJ, Castro de la Nuez P, Cernevskis H, de Los Ángeles Garcia Bazaga M, des Grottes JM, Fernández González R, Ferrer-Alamar M, Finne P, Garneata L, Golan E, Heaf JG, Hemmelder MH, Idrizi A, Ioannou K, Jarraya F, Kantaria N, Kolesnyk M, Kramar R, Lassalle M, Lezaic VV, Lopot F, Macario F, Magaz Á, Martín de Francisco AL, Martín Escobar E, Martínez Castelao A, Metcalfe W, Moreno Alia I, Nordio M, Ots-Rosenberg M, Palsson R, Ratkovic M, Resic H, Rutkowski B, Santiuste de Pablos C, Seyahi N, Fernanda Slon Roblero M, Spustova V, Stas KJF, Stendahl ME, Stojceva-Taneva O, Vazelov E, Ziginskiene E, Massy Z, Jager KJ, Stel VS.The European Renal Association – European Dialysis and Transplant Association Registry Annual Report 2014: a summary.Clin Kidney J. 2017 Apr;10(2):154-169.
Jager KJ, Fraser SD.The ascending rank of chronic kidney disease in the global burden of disease study.Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii121-ii128.
Stel VS, Brück K, Fraser S, Zoccali C, Massy ZA, Jager KJ.International differences in chronic kidney disease prevalence: a key public health and epidemiologic research issue.Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii129-ii135.
Tripepi G, D’Arrigo G, Jager KJ, Stel VS, Dekker FW, Zoccali C.Do we still need cross-sectional studies in Nephrology? Yes we do!Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii19-ii22.
Noordzij M, van Diepen M, Caskey FC, Jager KJ.Relative risk versus absolute risk: one cannot be interpreted without the other.Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii13-ii18.
van Diepen M, Ramspek CL, Jager KJ, Zoccali C, Dekker FW.Prediction versus aetiology: common pitfalls and how to avoid them.Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii1-ii5.
Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, Naicker S, Pecoits-Filho R, Yu XQ, Lameire N.Changes in the worldwide epidemiology of peritoneal dialysis.Nat Rev Nephrol. 2017 Feb;13(2):90-103.
van den Brand JA, Pippias M, Stel VS, Caskey FJ, Collart F, Finne P, Heaf J, Jais JP, Kramar R, Massy ZA, De Meester J, Traynor JP, Reisæter AV, Wetzels JF, Jager KJ.Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry.Nephrol Dial Transplant. 2017 Feb 1;32(2):348-355.
Farrington K, Covic A, Nistor I, Aucella F, Clyne N, De Vos L, Findlay A, Fouque D, Grodzicki T, Iyasere O, Jager KJ, Joosten H, Macias JF, Mooney A, Nagler E, Nitsch D, Taal M, Tattersall J, Stryckers M, van Asselt D, Van den Noortgate N, van der Veer S, van Biesen W.Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR<45 mL/min/1.73 m2): a summary document from the European Renal Best Practice Group.Nephrol Dial Transplant. 2017 Jan 1;32(1):9-16.
Ramspek CL, Nacak H, van Diepen M, van Buren M, Krediet RT, Rotmans JI, Dekker FW for the NECOSAD Study Group. Pre-dialysis decline of measured glomerular filtration rate but not serum creatinine-based estimated glomerular filtration rate is a risk factor for mortality on dialysis.Nephrol Dial Transplant. 2017 Jan 1;32(1):89-96.
2016
Hölttä T, Bonthuis M, Van Stralen KJ, Bjerre A, Topaloglu R, Ozaltin F, Holmberg C, Harambat J, Jager KJ, Schaefer F, Groothoff JW.Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA Registry.Pediatr Nephrol. 2016 Dec;31(12):2317-2325.
Mekahli D, van Stralen KJ, Bonthuis M, Jager KJ, Balat A, Benetti E, Godefroid N, Edvardsson VO, Heaf JG, Jankauskiene A, Kerecuk L, Marinova S, Puteo F, Seeman T, Zurowska A, Pirenne J, Schaefer F, Groothoff JW; ESPN/ERA-EDTA Registry.Kidney Versus Combined Kidney and Liver Transplantation in Young People With Autosomal Recessive Polycystic Kidney Disease: data from the European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant (ESPN/ERA-EDTA) Registry.Am J Kidney Dis. 2016 Nov;68(5):782-788.
Harambat J, Bonthuis M, Groothoff JW, Schaefer F, Tizard EJ, Verrina E, van Stralen KJ, Jager KJ.Lessons learned from the ESPN/ERA-EDTA Registry.Pediatr Nephrol. 2016 Nov;31(11):2055-2064.
Farrington K, Covic A, Aucella F, Clyne N, de Vos L, Findlay A, Fouque D, Grodzicki T, Iyasere O, Jager KJ, Joosten H, Macias JF, Mooney A, Nitsch D, Stryckers M, Taal M, Tattersall J, Van Asselt D, Van den Noortgate N, Nistor I, Van Biesen W; on behalf of the ERBP guideline development group.Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2).Nephrol Dial Transplant. 2016 Nov;31(suppl 2):ii1-ii66
Koopman JJ, Kramer A, van Heemst D, Åsberg A, Beuscart JB, Buturović-Ponikvar J, Collart F, Couchoud CG, Finne P, Heaf JG, Massy ZA, De Meester JM, Palsson R, Steenkamp R, Traynor JP, Jager KJ, Putter H.Measuring senescence rates of patients with end-stage renal disease while accounting for population heterogeneity: an analysis of data from the ERA-EDTA Registry.Ann Epidemiol. 2016 Nov;26(11):773-779.
Tjaden LA, Grootenhuis MA, Noordzij M, Groothoff JW.Health-related quality of life in patients with pediatric onset of end-stage renal disease: state of the art and recommendations for clinical practice.Pediatr Nephrol. 2016 Oct;31(10):1579-1591.
Pippias M, Stel VS, Aresté-Fosalba N, Couchoud C, Fernandez-Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Pálsson R, Ravani P, Segelmark M,Traynor JP, Reisæter AV, Caskey FJ, Jager KJ.Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry.Transplantation. 2016 Sep;100(9):1955-1962.
Poinen K, Oliver MJ, Ravani P, Van der Veer SN, Jager KJ, Van Biesen W, Polkinghorne KR, Rosenfeld A, Lewin AM, Dulai M, Quinn RR.Willingness to participate in a randomized trial comparing catheters to fistulas for vascular access in incident hemodialysis patients: an international survey of nephrologists.Can J Kidney Health Dis. 2016 Jul 13;3:33.
Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL.Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices.Lancet. 2016 Jul 16;388(10041):294-306.
Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, Kastarinen M, Guessous I, Vinhas J, Stengel B, Brenner H, Chudek J, Romundstad S, Tomson C, Gonzalez AO, Bello AK, Ferrieres J, Palmieri L, Browne G, Capuano V, Van Biesen W, Zoccali C, Gansevoort R, Navis G, Rothenbacher D, Ferraro PM, Nitsch D, Wanner C, Jager KJ; European CKD Burden Consortium.CKD Prevalence Varies across the European General Population.J Am Soc Nephrol. 2016 Jul;27(7):2135-2147.
Hogan J, Couchoud C, Bonthuis M, Groothoff JW, Jager KJ, Schaefer F, Van Stralen KJ.Gender Disparities in Access to Pediatric Renal Transplantation in Europe: Data from the ESPN/ERA-EDTA Registry.Am J Transplant. 2016 Jul;16(7):2097-2105.
van den Beukel TO, Hommel K, Kamper AL, Heaf JG, Siegert CE, Honig A, Jager KJ, Dekker FW, Norredam M.Differences in survival on chronic dialysis treatment between ethnic groups in Denmark: a population-wide, national cohort study.Nephrol Dial Transplant. 2016 Jul;31(7):1160-1167.
Chesnaye NC, Schaefer F, Groothoff JW, Bonthuis M, Reusz G, Heaf JG, Lewis M, Maurer E, Paripović D, Zagozdzon I, van Stralen KJ, Jager KJ.Mortality risk in European children with end-stage renal disease on dialysis.Kidney Int. 2016 Jun;89(6):1355-1362.
Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, Fliser D, Heine GH, Jager KJ, Gargani L, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Picano E, Rossignol P, Sarafidis P, Sicari R, Vanholder R, Wiecek A, London G, Zoccali C; European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis Transplantation Association (ERA-EDTA).Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles.Hypertension. 2016 Jun;67(6):1102-1110.
Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, Fliser D, Heine GH, Jager KJ, Gargani L, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Picano E, Rossignol P, Sarafidis P, Sicari R, Vanholder R, Wiecek A, London G, Zoccali C; European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association?European Dialysis Transplantation Association (ERA-EDTA).Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring: Methods, Thresholds, and Patterns.Hypertension. 2016 Jun;67(6):1093-1101.
van der Veer SN, van Biesen W, Bernaert P, Bolignano D, Brown EA, Covic A, Farrington K, Jager KJ, Kooman J, Macías-Núñez JF, Mooney A, van Munster BC, Topinkova E, Van Den Noortgate NJ, Wirnsberger G, Michel JP, Nistor I.Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults.Int Urol Nephrol. 2016 Jun;48(6):859-869.
Kramer A, Pippias M, Stel V, Bonthuis M, Abad Diez JM, Afentakis N, Alonso de la Torre R, Ambuhl P, Bikbov B, Bouzas Caamaño E, Bubic I, Buturovic-Ponikvar J, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Comas Farnés J, de los Ángeles Garcia Bazaga M, De Meester J, Ferrer Alamar M, Finne P, Garneata L, Golan E, Heaf JG, Hemmelder M, Ioannou K, Kantaria N, Kolesnyk M, Kramar R, Lassalle M, Lezaic V, Lopot F, Macário F, Magaz A, Martín-Escobar E, Metcalfe W, Ots-Rosenberg M, Palsson R, Piñera Celestino C, Resić H, Rutkowski B, Santiuste de Pablos C, Spustová V, Stendahl M, Strakosha A, Süleymanlar G, Torres Guinea M, Varberg Reisæter A, Vazelov E, Ziginskiene E, Massy ZA, Wanner C, Jager KJ, Noordzij M.Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus.Clin Kidney J. 2016 Jun;9(3):457-469.
Rao A, Brück K, Methven S, Evans R, Stel VS, Jager KJ, Hooft L, Ben-Shlomo Y, Caskey F.Quality of Reporting and Study Design of CKD Cohort Studies Assessing Mortality in the Elderly Before and After STROBE: A Systematic Review.PLoS One. 2016 May 11;11(5):e0155078.
Pippias M, Jager KJ, Kramer A, Leivestad T, Sánchez MB, Caskey FJ, Collart F, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hemmelder MH, Kramar R, De Meester J, Noordzij M, Palsson R, Pascual J, Zurriaga O, Wanner C, Stel VS.The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry.Nephrol Dial Transplant. 2016 May;31(5):831-841.
Brück K, Jager KJ, Dounousi E, Kainz A, Nitsch D, Ärnlöv J, Rothenbacher D, Browne G, Capuano V, Ferraro PM, Ferrieres J, Gambaro G, Guessous I,Hallan S, Kastarinen M, Navis G, Otero Gonzalez A, Palmieri L, Romundstad S, Spoto B, Stengel B, Tomson C, Tripepi G, Völzke H, Wiȩcek A, Gansevoort R,Schöttker B, Wanner C, Vinhas J, Zoccali C, Van Biesen W, Stel VS; European CKD Burden Consortium.Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review.ERRATUM.Nephrol Dial Transplant. 2016 Apr;31(4):680.
Tjaden LA, Maurice-Stam H, Grootenhuis MA, Jager KJ, Groothoff JW.Impact of Renal Replacement Therapy in Childhood on Long-Term Socioprofessional Outcomes: A 30-year Follow-Up Study.J Pediatr. 2016 Apr;171:189-195.
van Huis M, Bonthuis M, Sahpazova E, Mencarelli F, Spasojević B, Reusz G, Caldas-Afonso A, Bjerre A, Baiko S, Vondrak K, Molchanova EA, Kolvek G, Zaikova N, Böhm M, Ariceta G, Jager KJ, Schaefer F, van Stralen KJ, Groothoff JW.Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries-a report from the ESPN/ERA-EDTA registry.Nephrol Dial Transplant. 2016 Apr;31(4):609-619.
Koopman JJ, Rozing MP, Kramer A, Abad JM, Finne P, Heaf JG, Hoitsma AJ, De Meester JM, Palsson R, Postorino M, Ravani P, Wanner C, Jager KJ, van Bodegom D, Westendorp RG.Calculating the rate of senescence from mortality data: an analysis of data From the ERA-EDTA Registry.J Gerontol A Biol Sci Med Sci. 2016 Apr;71(4):468-474.
Tjaden LA, Noordzij M, van Stralen KJ, Kuehni CE, Raes A, Cornelissen EA, O’Brien C, Papachristou F, Schaefer F, Groothoff JW, Jager KJ; ESPN/ERA-EDTA Registry Study Group.Racial Disparities in Access to and Outcomes of Kidney Transplantation in Children, Adolescents, and Young Adults: Results From the ESPN/ERA-EDTA (European Society of Pediatric Nephrology/European Renal Association-European Dialysis and Transplant Association) Registry.Am J Kidney Dis. 2016 Feb;67(2):293-301.
Krischock LA, van Stralen KJ, Verrina E, Tizard EJ, Bonthuis M, Reusz G, Hussain FK, Jankauskiene A, Novljan G, Spasojević-Dimitrijeva B,Podracka L, Zaller V, Jager KJ, Schaefer F; ESPN/ERA-EDTA Registry.Anemia in children following renal transplantation-results from the ESPN/ERA-EDTA Registry.Pediatr Nephrol. 2016 Feb;31(2):325-333.
Lofaro D, Jager KJ, Abu-Hanna A, Groothoff JW, Arikoski P, Hoecker B, Roussey-Kesler G, Spasojević B, Verrina E, Schaefer F, van Stralen KJ; ESPN/ERA-EDTA Registry.Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry.Nephrol Dial Transplant. 2016 Feb;31(2):317-324.
Lofaro D, Vogelzang JL, van Stralen KJ, Jager KJ, Groothoff JW.Infection-related hospitalizations over 30 years of follow-up in patients starting renal replacement therapy at pediatric age. Pediatr Nephrol. 2016 Feb;31(2):315-323.
van de Luijtgaarden MW, Jager KJ, Segelmark M, Pascual J, Collart F, Hemke AC, Remón C, Metcalfe W, Miguel A, Kramar R, Aasarød K, Abu Hanna A, Krediet RT, Schön S, Ravani P, Caskey FJ, Couchoud C, Palsson R, Wanner C, Finne P, Noordzij M.Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period.Nephrol Dial Transplant. 2016 Jan;31(1):120-128.
2015
Ploos van Amstel S, Vogelzang JL, Starink MV, Jager KJ, Groothoff JW.Long-Term Risk of Cancer in Survivors of Pediatric ESRD.Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2198-2204.
Brück K, Stel VS, Fraser S, de Goeij MC, Caskey FJ, Abu-Hanna A, Jager KJ.Translational research in nephrology: chronic kidney disease prevention and public health.Clin Kidney J. 2015 Dec;8(6):647-655.
Van Biesen W, van de Luijtgaarden MW, Brown EA, Michel JP, van Munster BC, Jager KJ, van der Veer SN.Nephrologists’ perceptions regarding dialysis withdrawal and palliative care in Europe: lessons from a European Renal Best Practice survey.Nephrol Dial Transplant. 2015 Dec;30(12):1951-1958.
Rossignol P, Massy ZA, Azizi M, Bakris G, Ritz E, Covic A, Goldsmith D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Ortiz A, Vanholder R, Wiecek A, Zoccali C, London GM, Stengel B, Fouque D; ERA-EDTA EURECA-m working group; Red de Investigación Renal (REDINREN) network;Cardiovascular and Renal Clinical Trialists (F-CRIN INI-CRCT) network.The double challenge of resistant hypertension and chronic kidney disease.Lancet. 2015 Oct 17;386(10003):1588-1598.
Hellemans R, Stel VS, Jager KJ, Bosmans JL, Abramowicz D.Do elderly recipients really benefit from kidney transplantation?Transplant Rev (Orlando). 2015 Oct;29(4):197-201.
Hruskova Z, Stel VS, Jayne D, Aasarød K, De Meester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenéz C, Ravani P, Wanner C,Tesar V, Jager KJ.Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.Am J Kidney Dis. 2015 Oct;66(4):613-620.
Breckenridge K, Bekker HL, Gibbons E, van der Veer SN, Abbott D, Briançon S, Cullen R, Garneata L, Jager KJ, Lønning K, Metcalfe W, Morton RL, Murtagh FE, Prutz K, Robertson S, Rychlik I, Schon S, Sharp L, Speyer E, Tentori F, Caskey FJ.How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting.Nephrol Dial Transplant. 2015 Oct;30(10):1605-1614.
Wanner C, Jager KJ.Kidneys do not like excess body fat.Lancet Diabetes Endocrinol. 2015 Sep;3(9):669-671.
Ioannou K, Stel VS, Dounousi E, Jager KJ, Papagianni A, Pappas K, Siamopoulos KC, Zoccali C, Tsakiris D.Inflammation, Endothelial Dysfunction and Increased Left Ventricular Mass in Chronic Kidney Disease (CKD) Patients: A Longitudinal Study.PLoS One. 2015 Sep 23;10(9):e0138461.
Suttorp MM, Siegerink B, Jager KJ, Zoccali C, Dekker FW.Graphical presentation of confounding in directed acyclic graphs.Nephrol Dial Transplant. 2015 Sep;30(9):1418-1423.
Chesnaye NC, Schaefer F, Groothoff JW, Caskey FJ, Heaf JG, Kushnirenko S, Lewis M, Mauel R, Maurer E, Merenmies J, Shtiza D, Topaloglu R, Zaicova N, Zampetoglou A, Jager KJ, van Stralen KJ.Disparities in treatment rates of paediatric end-stage renal disease across Europe: insights from the ESPN/ERA-EDTA registry.Nephrol Dial Transplant. 2015 Aug;30(8):1377-1385.
Brück K, Jager KJ, Dounousi E, Kainz A, Nitsch D, Ärnlöv J, Rothenbacher D, Browne G, Capuano V, Ferraro PM, Ferrieres J, Gambaro G, Guessous I, Hallan S, Kastarinen M, Navis G, Gonzalez AO, Palmieri L, Romundstad S, Spoto B, Stengel B, Tomson C, Tripepi G, Völzke H, Wiȩcek A, Gansevoort R, Schöttker B, Wanner C, Vinhas J, Zoccali C, Van Biesen W, Stel VS; European CKD Burden Consortium.Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review.Nephrol Dial Transplant. 2015 Aug;30 Suppl 4:iv6-iv16.
Kainz A, Hronsky M, Stel VS, Jager KJ, Geroldinger A, Dunkler D, Heinze G, Tripepi G, Oberbauer R.Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025.Nephrol Dial Transplant. 2015 Aug;30 Suppl 4:iv113-iv118.
Leffondre K, Boucquemont J, Tripepi G, Stel VS, Heinze G, Dunkler D.Analysis of risk factors associated with renal function trajectory over time: a comparison of different statistical approaches.Nephrol Dial Transplant. 2015 Aug;30(8):1237-1243.
Stel VS, Heinze G, Tripepi G, Zoccali C, Jager KJ.Seven essential tools of a cardiologist’s survival kit.Int J Cardiol. 2015 Jul 15;191:87-89.
Haller MC, van der Veer SN, Nagler EV, Tomson C, Lewington A, Hemmelgarn BR, Gallagher M, Rocco M, Obrador G, Vanholder R, Craig JC, van Biesen W. A survey on the methodological processes and policies of renal guideline groups as a first step to harmonize renal guidelines.Nephrol Dial Transplant. 2015 Jul;30(7):1066-1074.
de Vos MLG, van der Veer SN, Wouterse B, Graafmans WC, Peek N, de Keizer NF, Jager KJ, Westert GP, van der Voort PHJ. A multifaceted feedback strategy alone does not improve the adherence to organizational guideline-based standards: a cluster randomized trial in intensive care.Implementation Sci. 2015 Jul 8;10:95.
Zoccali C, Bolignano D, D’Arrigo G, Dekker FW, Fliser D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Parati G, Rossignol P, Tripepi G, Vanholder R, Wiecek A, London G; European Renal and Cardiovascular Medicine (EURECA-m), Working Group of the European Renal Association-European Dialysis Transplantation Association (ERA-EDTA).Validity of Vascular Calcification as a Screening Tool and as a Surrogate End Point in Clinical Research.Hypertension. 2015 Jul;66(1):3-9.
Vogelzang JL, van Stralen KJ, Noordzij M, Diez JA, Carrero JJ, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hoitsma A, Leivestad T, de Meester J, Metcalfe W, Palsson R, Postorino M, Ravani P, Vanholder R, Wallner M, Wanner C, Groothoff JW, Jager KJ.Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry.Nephrol Dial Transplant. 2015 Jun;30(6):1028-1037.
Jager KJ, Wanner C.Fifty years of ERA-EDTA Registry-a registry in transition.Kidney Int Suppl (2011). 2015 Jun;5(1):12-14.
Pippias M, Stel VS, Abad Diez JM, Afentakis N, Herrero-Calvo JA, Arias M, Tomilina N, Bouzas Caamaño E, Buturovic-Ponikvar J, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Alonso de la Torre R, García Bazaga Mde L, De Meester J, Díaz JM, Djukanovic L, Ferrer Alamar M, Finne P, Garneata L, Golan E, González Fernández R, Gutiérrez Avila G, Heaf J, Hoitsma A, Kantaria N, Kolesnyk M, Kramar R, Kramer A, Lassalle M, Leivestad T, Lopot F, Macário F, Magaz A, Martín-Escobar E, Metcalfe W, Noordzij M, Palsson R, Pechter Ü,Prütz KG, Ratkovic M, Resić H, Rutkowski B, Santiuste de Pablos C, Spustová V, Süleymanlar G, Van Stralen K, Thereska N, Wanner C,Jager KJ.Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report.Clin Kidney J. 2015 Jun;8(3):248-261.
Bonthuis M, Busutti M, van Stralen KJ, Jager KJ, Baiko S, Bakkaloğlu S, Battelino N, Gaydarova M, Gianoglio B, Parvex P, Gomes C, Heaf JG, Podracka L, Kuzmanovska D, Molchanova MS, Pankratenko TE, Papachristou F, Reusz G, Sanahuja MJ, Shroff R, Groothoff JW, Schaefer F, Verrina E.Mineral metabolism in European children living with a renal transplant: a European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplant Association Registry study.Clin J Am Soc Nephrol. 2015 May 7;10(5):767-775.
Tripepi G, Heinze G, Jager KJ, Stel VS, Dekker FW, Zoccali C.Lag-censoring analysis: lights and shades.Nephrol Dial Transplant. 2015 May;30(5):700-705.
Bilo H, Coentrão L, Couchoud C, Covic A, De Sutter J, Drechsler C, Gnudi L, Goldsmith D, Heaf J, Heimburger O, Jager KJ, Nacak H, Soler MJ, Van Huffel L, Tomson C, Van Laecke S, Weekers L, Wieçek A, Bolignano D, Haller M, Nagler E, Nistor I, van der Veer S, Van Biesen W.Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min).Nephrol Dial Transplant. 2015 May;30 Suppl 2:ii1-142.
Goldsmith D, Covic A, Vervloet M, Cozzolino M, Nistor I for the Chronic Kidney Disease-Mineral Bone Disease (CKD-MBD) working group and the European Renal Best Practice (ERBP) advisory board.Should patients with CKD stage 5 be prescribed calcimimetic therapy.Nephrol Dial Transplant. 2015 May;30(5):698–700.
van der Veer SN, Ravani P, Coentrão L, Fluck R, Kleophas W, Labriola L, Hoischen SH, Noordzij M, Jager KJ, van Biesen W.Barriers to adopting a fistula-first policy in Europe: an international survey among national experts.J Vasc Access. 2015 Mar-Apr;16(2):113-119.
Couchoud C, Bolignano D, Nistor I, Jager KJ, Heaf J, Heimburger O, Van Biesen W; European Renal Best Practice (ERBP) Diabetes Guideline Development Group.Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence.Nephrol Dial Transplant. 2015 Feb;30(2):310-320.
van Dijk PR, Kramer A, Logtenberg SJ, Hoitsma AJ, Kleefstra N, Jager KJ, Bilo HJ.Incidence of renal replacement therapy for diabetic nephropathy in the Netherlands: Dutch diabetes estimates (DUDE)-3.BMJ Open. 2015 Jan 30;5(1):e005624.
2014
Chesnaye N, Bonthuis M, Schaefer F, Groothoff JW, Verrina E, Heaf JG, Jankauskiene A, Lukosiene V, Molchanova EA, Mota C, Peco-Antić A, Ratsch IM, Bjerre A, Roussinov DL, Sukalo A, Topaloglu R, Van Hoeck K, Zagozdzon I, Jager KJ, Van Stralen KJ; on behalf of the ESPN/ERA-EDTA registry.Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry.Pediatr Nephrol.2014 Dec;29(12):2403-2410.
Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, Collart F, Finne P, Fogarty DG, Groothoff JW, Hoitsma A, Nogier MB, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT; on behalf of the ERA-EDTA Registry; EuroCYST Consortium; the WGIKD.Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.Kidney Int. 2014 Dec;86(6):1244-1252.
Noordzij M, Jager KJ.Patient survival on dialysis in Korea: a different story?Kidney Int. 2014 Nov;86(5):877-880.
Wolbers M, Koller MT, Stel VS, Schaer B, Jager KJ, Leffondré K, Heinze G.Competing risks analyses: objectives and approaches.Eur Heart J. 2014 Nov 7;35(42):2936-2941.
Leffondré K, Jager KJ, Boucquemont J, Stel VS, Heinze G.Representation of exposures in regression analysis and interpretation of regression coefficients: basic concepts and pitfalls.Nephrol Dial Transplant. 2014 Oct;29(10):1806-1814.
Noordzij M, Jager KJ, van der Veer SN, Kramar R, Collart F, Heaf JG, Stojceva-Taneva O, Leivestad T, Buturovic-Ponikvar J, Benítez Sánchez M, Moreso F, Prütz KG, Severn A, Wanner C, Vanholder R, Ravani P.Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry.Nephrol Dial Transplant. 2014 Oct;29(10):1956-1964.
Wühl E, van Stralen KJ, Wanner C, Ariceta G, Heaf JG, Bjerre AK, Palsson R, Duneau G, Hoitsma AJ, Ravani P, Schaefer F, Jager KJ.Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry.Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv1-iv8.
Spithoven EM, Kramer A, Meijer E, Orskov B Wanner C, Abad JM, Aresté N, Alonso de la Torre R, Caskey F, Couchoud C, Finne P, Heaf J, Hoitsma A, de Meester J, Pascual J, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT; ERA-EDTA Registry; EuroCYST Consortium; WGIKD; ERA-EDTA Registry.Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry.Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv15-iv25.
Radhakrishnan J, Remuzzi G, Saran R, Williams DE, Rios-Burrows N, Powe N; CDC-CKD Surveillance Team, Brück K, Wanner C, Stel VS; European CKD Burden Consortium, Venuthurupalli SK, Hoy WE, Healy HG, Salisbury A, Fassett RG; CKD.QLD group, O’Donoghue D, Roderick P, Matsuo S, Hishida A, Imai E, Iimuro S.Taming the chronic kidney disease epidemic: a global view of surveillance efforts.Kidney Int. 2014 Aug;86(2):246-250.
Tjaden LA, Vogelzang J, Jager KJ, van Stralen KJ, Maurice-Stam H, Grootenhuis MA, Groothoff JW.Long-term quality of life and social outcome of childhood end-stage renal disease.J Pediatr. 2014 Aug;165(2):336-342.
Caskey FJ, Jager KJ.A population approach to renal replacement therapy epidemiology: lessons from the EVEREST study.Nephrol Dial Transplant. 2014 Aug;29(8):1494-1499.
van der Veer SN, van Biesen W, Couchoud C, Tomson CR, Jager KJ.Measuring the quality of renal care: things to keep in mind when selecting and using quality indicators.Nephrol Dial Transplant. 2014 Aug;29(8):1460-1467.
van Stralen KJ, Borzych-Dużalka D, Hataya H, Kennedy SE, Jager KJ, Verrina E, Inward C, Rönnholm K, Vondrak K, Warady BA, Zurowska AM, Schaefer F, Cochat P.Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period.Kidney Int. 2014 Jul;86(1):168-174.
Kolesnyk I, Noordzij M, Kolesnyk M, Kulyzky M, Jager KJ.Renal replacement therapy in Ukraine: epidemiology and international comparisons.Clin Kidney J. 2014 Jun;7(3):330-335.
van der Veer SN, Tomson CR, Jager KJ, van Biesen W.Bridging the gap between what is known and what we do in renal medicine: improving implementability of the European Renal Best Practice guidelines.Nephrol Dial Transplant. 2014 May;29(5):951-957.
Noordzij M, Kramer A, Abad Diez JM, Alonso de la Torre R, Arcos Fuster E, Bikbov B, Bonthuis M, Bouzas Caamaño E, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Díaz Tejeiro R, Djukanovic L, Ferrer-Alamar M, Finne P, de los Angelos García Bazaga M, Garneata L, Golan E, Gonzalez Fernández R, Heaf JG, Hoitsma A, Ioannidis GA, Kolesnyk M, Kramar R, Lasalle M, Leivestad T, Lopot F, van de Luijtgaarden M, Macário F, Magaz A, Martín Escobar E, de Meester J, Metcalfe W, Ots-Rosenberg M, Palsson R, Piñera C, Pippias M , Prütz KG, Ratkovic M, Resić H, Rodríguez Hernández A, Rutkowski B, Spustová V, Stel VS, Stojceva-Taneva O, Süleymanlar G, Wanner C, Jager KJRenal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry annual report.Clin Kidney J. 2014 Apr;7(2):227-238.
Boucquemont J, Heinze G, Jager KJ, Oberbauer R, Leffondre K.Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the art.BMC Nephrol. 2014 Mar 14;15:45.
Harambat J, van Stralen KJ, Verrina E, Groothoff JW, Schaefer F, Jager KJ.Likelihood of children with end-stage kidney disease in Europe to live with a functioning kidney transplant is mainly explained by nonmedical factors.Pediatr Nephrol. 2014 Mar;29(3):453-459.
Bonthuis M, van Stralen KJ, Jager KJ, Baiko S, Jahnukainen T, Laube GF, Podracka L, Seeman T, Tyerman K, Ulinski T, Groothoff JW, Schaefer F, Verrina E.Dyslipidaemia in children on renal replacement therapy.Nephrol Dial Transplant. 2014 Mar;29(3):594-603.
Harambat J, Bonthuis M, van Stralen KJ, Ariceta G, Battelino N, Bjerre A, Jahnukainen T, Leroy V, Reusz G, Sandes AR, Sinha MD, Groothoff JW, Combe C, Jager KJ, Verrina E, Schaefer F; ESPN/ERA-EDTA Registry.Adult height in patients with advanced CKD requiring renal replacement therapy during childhood.Clin J Am Soc Nephrol. 2014 Jan;9(1):92-99.
Noordzij M, Jager KJ.Increased mortality early after dialysis initiation: a universal phenomenon.Kidney Int. 2014 Jan;85(1):12-14.
2013
Stel VS, Ioannou K, Brück K, Dounousi E, Pappas K, Siamopoulos KC, Zoccali C, Jager KJ, Tsakiris D.Longitudinal association of body mass index and waist circumference with left ventricular mass in hypertensive predialysis chronic kidney disease patients.Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv136-iv145.
Bonthuis M, van Stralen KJ, Verrina E, Groothoff JW, Alonso Melgar A, Edefonti A, Fischbach M, Mendes P, Molchanova EA, Paripovic D, Peco-Antic A, Printza N, Rees L, Rubik J, Stefanidis CJ, Sinha MD, Zagozdzon I, Jager KJ, Schaefer F.Underweight, overweight and obesity in paediatric dialysis and renal transplant patients.Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv195-iv204.
Noordzij M, Leffondré K, van Stralen KJ, Zoccali C, Dekker FW, Jager KJ.When do we need competing risks methods for survival analysis in nephrology?Nephrol Dial Transplant. 2013 Nov;28(11):2670-2677.
van de Luijtgaarden MW, Noordzij M, van Biesen W, Couchoud C, Cancarini G, Bos WJ, Dekker FW, Gorriz JL, Iatrou C, Wanner C, Finne P, Stojceva-Taneva O, Cala S, Stel VS, Tomson C, Jager KJ.Conservative care in Europe–nephrologists’ experience with the decision not to start renal replacement therapy.Nephrol Dial Transplant. 2013 Oct;28(10):2604-2612.
Vogelzang JL, Heestermans LW, van Stralen KJ, Jager KJ, Groothoff JW.Simultaneous reversal of risk factors for cardiac death and intensified therapy in long-term survivors of paediatric end-stage renal disease over the last 10 years.Nephrol Dial Transplant. 2013 Oct;28(10):2545-2552.
Evans M, van Stralen KJ, Schön S, Prütz KG, Stendahl M, Rippe B, Jager KJ.Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease.Nephrol Dial Transplant. 2013 Oct;28(10):2518-2526.
de Goeij MC, van Diepen M, Jager KJ, Tripepi G, Zoccali C, Dekker FW.Multiple imputation: dealing with missing data.Nephrol Dial Transplant. 2013 Oct;28(10):2415-2420.
Couchoud C, Lassalle M, Cornet R, Jager KJ.Renal replacement therapy registries–time for a structured data quality evaluation programme.Nephrol Dial Transplant. 2013 Sep;28(9):2215-2220.
Schroijen MA, van de Luijtgaarden MW, Noordzij M, Ravani P, Jarraya F, Collart F, Prütz KG, Fogarty DG, Leivestad T, Prischl FC, Wanner C, Dekker FW, Jager KJ, Dekkers OM.Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition.Diabetologia. 2013 Sep;56(9):1949-1957.
Van Biesen W, van der Veer SN, Jager KJ, Fouque D, Wanner C, Vanholder R.What guidelines should or should not be: implications for guideline production.Nephrol Dial Transplant. 2013 Aug;28(8):1980-1984.
Tripepi G, Heinze G, Jager KJ, Stel VS, Dekker FW, Zoccali C.Risk prediction models.Nephrol Dial Transplant. 2013 Aug;28(8):1975-1980.
Vogelzang JL, van Stralen KJ, Jager KJ, Groothoff JW.Trend from cardiovascular to non-cardiovascular late mortality in patients with renal replacement therapy since childhood.Nephrol Dial Transplant. 2013 Aug;28(8):2082-2089.
Harambat J, van Stralen KJ, Schaefer F, Grenda R, Jankauskiene A, Kostic M, Macher MA, Maxwell H, Puretic Z, Raes A, Rubik J, Sørensen SS, Toots U, Topaloglu R, Tönshoff B, Verrina E, Jager KJ.Disparities in Policies, Practices and Rates of Pediatric Kidney Transplantation in Europe.Am J Transplant. 2013 Aug;13(8):2066-2074.
Bonthuis M, Jager KJ, Abu-Hanna A, Verrina E, Schaefer F, van Stralen KJ.Application of body mass index according to height-age in short and tall children.PLoS One. 2013 Aug 7;8(8):e72068.
Stel VS, Dekker FW, Zoccali C, Jager KJ.Instrumental variable analysis.Nephrol Dial Transplant. 2013 Jul; 28(7):1694-1699.
van de Luijtgaarden MW, Jager KJ, Stel VS, Kramer A, Cusumano A, Elliott RF, Geue C, Macleod AM, Stengel B, Covic A, Caskey FJ.Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators.Nephrol Dial Transplant. 2013 May;28(5):1264-1275.
Wanner C, Jager KJ.Cardiovascular disease: Is CABG really better than PCI in dialysis patients?Nat Rev Nephrol. 2013 Apr;9(4):197-198.
Van Stralen KJ, Verrina E, Belingheri M, Dudley J, Dusek J, Grenda R, Macher MA, Puretic Z, Rubic J, Rudaitis S, Rudin C, Schaefer F, Jager KJ.Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric population.Nephrol Dial Transplant. 2013 Apr;28(4):1031-1038.
Kramer A, Stel VS, Abad Diez JM, Alonso de la Torre R, Bouzas Caamaño E, Cala S, Cao Baduell H, Castro de la Nuez P, Cernevskis H, Collart F, Couchoud C, de Meester J, Djukanovic L, Ferrer-Alamar M, Finne P, Fogarty D, García Bazaga M de los A, Garneata L, Golan E, Gonzalez Fernández R, Heaf JG, Hoitsma A, Ioannidis GA, Kolesnyk M, Kramar R, Leivestad T, Limido A, Lopot F, Macario F, Magaz A, Martín-Escobar E, Metcalfe W, Noordzij M, Ots-Rosenberg M, Palsson R, Piñera C, Postorino M, Prütz KG, Ratkovic M, Resic H, Rodríguez Hernández A, Rutkowski B, Serdengeçti K, Sierra Yebenes T, Spustová V, Stojceva-Taneva O, Tomilina NA, van de Luijtgaarden MW, van Stralen KJ, Wanner C, Jager KJ.Renal replacement therapy in Europe – a summary of the 2010 ERA-EDTA Registry Annual ReportClin Kidney J. 2013 Feb;6(1):105-115.
Wühl E, van Stralen KJ, Verrina E, Bjerre A, Wanner C, Heaf JG, Zurriaga O, Hoitsma A, Niaudet P, Palsson R, Ravani P, Jager KJ, Schaefer F.Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract.Clin J Am Soc Nephrol. 2013 Jan;8(1):67-74.
2012
Kramer A, Jager KJ, Fogarty DG, Ravani P, Finne P, Pérez-Panadés J, Prütz KG, Arias M, Heaf JG, Wanner C, Stel VS.Association between pre-transplant dialysis modality and patient and graft survival after kidney transplantation.Nephrol Dial Transplant. 2012 Dec;27(12):4473-4480.
Venkat-Raman G, Tomson CR, Gao Y, Cornet R, Stengel B, Gronhagen-Riska C, Reid C, Jacquelinet C, Schaeffner E, Boeschoten E, Casino F, Collart F, De Meester J, Zurriaga O, Kramar R, Jager KJ, Simpson K.New primary renal diagnosis codes for the ERA-EDTA.Nephrol Dial Transplant. 2012 Dec;27(12):4414-4419.
Temme J, Kramer A, Jager KJ, Lange K, Peters F, Müller GA, Kramar R, Heaf JG, Finne P, Palsson R, Reisæter AV, Hoitsma AJ, Metcalfe W, Postorino M, Zurriaga O, Santos JP, Ravani P, Jarraya F, Verrina E, Dekker FW, Gross O.Outcomes of Male Patients with Alport Syndrome Undergoing Renal Replacement Therapy.Clin J Am Soc Nephrol. 2012 Dec;7(12):1969-1976.
Ocak G, van Stralen KJ, Rosendaal FR, Verduijn M, Ravani P, Palsson R, Leivestad T, Hoitsma AJ, Ferrer-Alamar M, Finne P, De Meester J, Wanner C, Dekker FW, Jager KJ.Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients.J Thromb Haemost. 2012 Dec;10(12):2484-2493.
van de Luijtgaarden MW, Noordzij M, Tomson C, Couchoud C, Cancarini G, Ansell D, Bos WJ, Dekker FW, Gorriz JL, Iatrou C, Garneata L, Wanner C, Cala S, Stojceva-Taneva O, Finne P, Stel VS, van Biesen W, Jager KJ.Factors Influencing the Decision to Start Renal Replacement Therapy: Results of a Survey Among European Nephrologists.Am J Kidney Dis. 2012 Dec;60(6):940-948.
Bonthuis M, van Stralen KJ, Verrina E, Edefonti A, Molchanova EA, Hokken-Koelega AC, Schaefer F, Jager KJ.Use of national and international growth charts for studying height in European children: development of up-to-date European height-for-age charts.PLoS One. 2012;7(8):e42506.
van der Veer SN, Arah OA, Visserman E, Bart HA, de Keizer NF, Abu-Hanna A, Heuveling LM, Stronks K, Jager KJ.Exploring the relationships between patient characteristics and their dialysis care experience.Nephrol Dial Transplant. 2012 Nov;27(11):4188-4196.
Kramer A, Stel VS, Caskey FJ, Stengel B, Elliott RF, Covic A, Geue C, Cusumano A, Macleod AM, Jager KJ.Exploring the Association between Macroeconomic Indicators and Dialysis Mortality.Clin J Am Soc Nephrol. 2012 Oct;7(10):1655-1663.
Jager KJ, Ocak G, Drechsler C, Caskey FJ, Evans M, Postorino M, Dekker FW, Wanner C.The EQUAL study: a European study in chronic kidney disease stage 4 patients.Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii27-iii31.
van Stralen KJ, Krischock L, Schaefer F, Verrina E, Groothoff JW, Evans J, Heaf J, Ivanov D, Kostic M, Maringhini S, Podracká L, Printza N, Pundziene B, Reusz GS, Vondrak K, Jager KJ, Tizard EJ; on behalf of the ESPN/ERA-EDTA Registry.Prevalence and predictors of the sub-target Hb level in children on dialysis.Nephrol Dial Transplant. 2012 Oct;27(10):3950-3957.
Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F, Snyder HJ, Choi M, Hou P, Scolari F, Izzi C, Gigante M, Gesualdo L, Savoldi S, Amoroso A, Cusi D, Zamboli P, Julian BA, Novak J, Wyatt RJ, Mucha K, Perola M, Kristiansson K, Viktorin A, Magnusson PK, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Boland A, Metzger M, Thibaudin L, Wanner C, Jager KJ, Goto S, Maixnerova D, Karnib HH, Nagy J, Panzer U, Xie J, Chen N, Tesar V, Narita I, Berthoux F, Floege J, Stengel B, Zhang H, Lifton RP, Gharavi AG.Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis.PLoS Genet. 2012;8(6):e1002765.
van Stralen KJ, Dekker FW, Zoccali C, Jager KJ.Measuring Agreement, More Complicated Than It Seems.Nephron Clin Pract. 2012;120(3):c162-c167.
Stel VS, Kramar R, Leivestad T, Hoitsma AJ, Metcalfe W, Smits JM, Ravani P, Jager KJ.Time trend in access to the waiting list and renal transplantation: a comparison of four European countries.Nephrol Dial Transplant. 2012 Sep;27(9):3621-3631.
Noordzij M, Jager KJ.Survival comparisons between haemodialysis and peritoneal dialysis.Nephrol Dial Transplant. 2012 Sep;27(9):3385-3387.
van der Veer SN, Jager KJ, Visserman E, Beekman RJ, Boeschoten EW, de Keizer NF, Heuveling L, Stronks K, Arah OA.Development and validation of the Consumer Quality index instrument to measure the experience and priority of chronic dialysis patients.Nephrol Dial Transplant. 2012 Aug;27(8):3284-3291.
Van Biesen W, Dekker F, Heimburger O, Jager K, Lameire N, Lindley E, Vanholder R, Zoccali C, Tattersall J.European guidelines on when to start dialysis: check the facts first before commenting.Kidney Int. 2012 Jun;81(11):1149.
van den Beukel TO, Verduijn M, le Cessie S, Jager KJ, Boeschoten EW, Krediet RT, Siegert CE, Honig A, Dekker FW.The role of psychosocial factors in ethnic differences in survival on dialysis in the Netherlands.Nephrol Dial Transplant. 2012 Jun;27(6):2472-2479.
Susantitaphong P, Altamimi S, Ashkar M, Balk EM, Stel VS, Wright S, Jaber BL.GFR at initiation of dialysis and mortality in CKD: a meta-analysis.Am J Kidney Dis. 2012 Jun;59(6):829-840.
van de Luijtgaarden MWM, Noordzij M, Wanner C, Jager KJ.Renal replacement therapy in Europe – a summary of the 2009 ERA-EDTA Registry Annual Report.Clin Kidney J. 2012 Apr;5(2):109-119.
Harambat J, van Stralen KJ, Espinosa L, Groothoff JW, Hulton SA, Cerkauskiene R, Schaefer F, Verrina E, Jager KJ, Cochat P.Characteristics and Outcomes of Children with Primary Oxalosis Requiring Renal Replacement Therapy.Clin J Am Soc Nephrol. 2012 Mar;7(3):458-465.
Kramer A, Stel VS, Geskus RB, Tizard EJ, Verrina E, Schaefer F, Heaf JG, Kramar R, Krischock L, Leivestad T, Pálsson R, Ravani P, Jager KJ.The effect of timing of the first kidney transplantation on survival in children initiating renal replacement therapy.Nephrol Dial Transplant. 2012 Mar;27(3):1256-1264.
Harambat J, van Stralen KJ, Kim JJ, Tizard EJ.Epidemiology of chronic kidney disease in children.Pediatr Nephrol. 2012 Mar;27(3):363-373. Erratum in: Pediatr Nephrol. 2012; 27:507.
Visser A, Noordzij M, Gansevoort RT, Van Biesen W, Reijneveld SA, Jager KJ, de Jong PE, Izaks GJ, Dijkstra GJ, De Meester J, Hoitsma AJ, Franssen CF.Exploration of the difference in incidence of renal replacement therapy between Flanders and the Netherlands–investigation of explanatory variables.Nephrol Dial Transplant. 2012 Feb;27(2):803-809.
Visser A, Sunaert P, Franssen CF, Van Biesen W, Reijneveld SA, Jager KJ, de Jong PE, Izaks GJ, Dijkstra GJ, Gansevoort RT.Exploration of the difference in incidence of renal replacement therapy in elderly patients in Flanders and the Netherlands–a comparison of referral policy.Nephrol Dial Transplant. 2012 Jan;27(1):338-344.
2011
van Stralen KJ, Wanner C, Jager KJ.Long interdialytic interval and mortality.N Engl J Med.2011 Dec 22;365(25): 2437.
Schroijen MA, Dekkers OM, Grootendorst DC, Noordzij M, Romijn JA, Krediet RT, Boeschoten EW, Dekker FW.Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition.BMC Nephrol. 2011 Dec 19;12:69.
Kramer AM, van Stralen KJ, Jager KJ, Schaefer F, Verrina E, Seeman T, Lewis MA, Boehm M, Simonetti GD, Novljan G, Groothoff JW.Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe.Kidney Int. 2011 Nov;80(10): 1092-1098.
van der Veer SN, Jager KJ, Nache AM, Richardson D, Hegarty J, Couchoud C, de Keizer NF, Tomson CR.Translating knowledge on best practice into improving quality of RRT care: a systematic review of implementation strategies.Kidney Int. 2011 Nov;80(10): 1021-1034.
van der Veer SN, de Vos MLG, Jager KJ, van der Voort PHJ, Peek N, Westert GP, Graafmans WC, de Keizer NF. Evaluating the effectiveness of a tailored multifaceted performance feedback intervention to improve the quality of care: protocol for a cluster randomized trial in intensive care. Implement Sci. 2011 Oct 24;6:119.
van Stralen KJ, Emma F, Jager KJ, Verrina E, Schaefer F, Laube GF, Lewis MA, Levtchenko EN.Improvement in the Renal Prognosis in Nephropathic Cystinosis.Clin J Am Soc Nephrol. 2011 Oct;6(10): 2485-2491.
Noordzij M, Zoccali C, Dekker FW, Jager KJ.Adding up the evidence: systematic reviews and meta-analyses.Nephron Clin Pract. 2011;119(4): c310-c316.
Stel VS, Dekker FW, Tripepi G, Zoccali C, Jager KJ.Survival analysis II: cox regression.Nephron Clin Pract. 2011;119(3): c255-c260.
Verduijn M, Jager KJ, Zoccali C, Dekker FW.Genetic association studies: discovery of the genetic basis of renal disease.Nephron Clin Pract. 2011;119(3): c236-c239.
de Jager DJ, de Mutsert R, Jager KJ, Zoccali C, Dekker FW.Reporting of interaction.Nephron Clin Pract. 2011;119(2): c158-c161.
de Mutsert R, de Jager DJ, Jager KJ, Zoccali C, Dekker FW.Interaction on an additive scale.Nephron Clin Pract. 2011;119(2): c154-c157.
Stel VS, Dekker FW, Tripepi G, Zoccali C, Jager KJ.Survival Analysis I: The Kaplan-Meier Method.Nephron Clin Pract. 2011;119(1): c83-c88.
van de Luijtgaarden MW, Noordzij M, Stel VS, Ravani P, Jarraya F, Collart F, Schön S, Leivestad T, Puttinger H, Wanner C, Jager KJ.Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe.Nephrol Dial Transplant. 2011 Sep;26(9): 2940-2947.
Caskey FJ, Kramer A, Elliott RF, Stel VS, Covic A, Cusumano A, Geue C, Macleod AM, Zwinderman AH, Stengel B, Jager KJ.Global variation in renal replacement therapy for end-stage renal disease.Nephrol Dial Transplant. 2011 Aug;26(8): 2604-2610.
Tattersall J, Dekker F, Heimbürger O, Jager KJ, Lameire N, Lindley E, Van Biesen W, Vanholder R, Zoccali C; on behalf of the ERBP Advisory board.When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study.Nephrol Dial Transplant 2011 Jul;26(7): 2082-2086.
Carrero JJ, de Jager DJ, Verduijn M, Ravani P, De Meester J, Heaf JG, Finne P, Hoitsma AJ, Pascual J, Jarraya F, Reisaeter AV, Collart F, Dekker FW, Jager KJ.Cardiovascular and noncardiovascular mortality among men and women starting dialysis.Clin J Am Soc Nephrol. 2011 Jul;6(7): 1722-1730.
Grootendorst DC, Michels WM, Richardson JD, Jager KJ, Boeschoten EW, Dekker FW, Krediet RT; for the NECOSAD Study Group.The MDRD formula does not reflect GFR in ESRD patients.Nephrol Dial Transplant. 2011 Jun;26(6):1932-1937.
Jager KJ, Lindholm B, Goldsmith D, Fliser D, Wiecek A, Suleymanlar G, Ortiz A, Massy Z, Martinez-Castelao A, Agarwal A, Blankestijn P, Covic A, London G, Zoccali C, Dekker FW for the EURECA-m Working Group.Cardiovascular and non-cardiovascular mortality in dialysis patients – where is the link?Kidney Int Sup 2011 Jun;1(1):21-23.
Agarwal R, Martinez-Castelao A, Wiecek A, Massy Z, Suleymanlar G, Ortiz A, Blankestijn PJ, Covic A, Dekker FW, Jager KJ, Lindholm B, Goldsmith D, Fliser D, London G, Zoccali C for the EURECA-m Working Group.The lingering dilemma of arterial pressure in CKD: what do we know, where do we go?Kidney Int Sup 2011 Jun;1(1):17-20.
Blankestijn PJ, LondonG, Fliser D, Jager KJ, Lindholm B, Goldsmith D, Wiecek A, Suleymanlar G, Agarwal R, Ortiz A, Massy Z, Martinez-Castelao A, Covic A, Dekker FW, Zoccali C for the EURECA-m Working Group.Major pathways of the reno – cardiovascular link: the sympathetic and renin-angiotensin systems.Kidney Int Sup 2011 Jun;1(1):13-16.
London G, Covic A, Goldsmith D, Wiecek A, Suleymanlar G, Ortiz A, Massy Z, Lindholm B, Martinez-Castelao A, Fliser D, Agarwal R, Jager KJ, Dekker FW, Blankestijn P, Zoccali C for the EURECA-m Working Group.Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work and organ flow – Implications for CKD and cardiovascular disease.Kidney Int Sup 2011 Jun;1(1):10-12.
Fliser D, Wiecek A, Suleymanlar G, Ortiz A, Massy Z, Lindholm B, Martinez-Castelao A, Agarwal R, Jager KJ, Dekker FW, Blankestijn P, Goldsmith D, Covic A, London G, Zoccali C for the EURECA-m Working Group.The dysfunctional endothelium in CKD and in cardiovascular disease – Mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda.Kidney Int Sup 2011 Jun;1(1):6-9.
Zoccali C, Goldsmith D, Agarwal R, Blankestijn P, Fliser D, Wiecek A, Suleymanlar G, Ortiz A, Massy Z, Covic A, Martinez-Castelao A, Jager KJ, Dekker FW, Lindholm B, London G for the EURECA-m Working Group.The complexity of the cardio-renal link: taxonomy, syndromes and diseases.Kidney Int Sup 2011 Jun;1(1):2-5.
Tripepi G, Jager KJ, Stel VS, Dekker FW, Zoccali C.How to deal with continuous and dichotomic outcomes in epidemiological research: linear and logistic regression analyses.Nephron Clin Pract. 2011;118(4):c399-c406.
Noordzij M, Dekker FW, Zoccali C, Jager KJ.Sample size calculations.Nephron Clin Pract. 2011;118(4):c319-c323.
de Graaf MA, Jager KJ, Zoccali C, Dekker FW.Matching, an appealing method to avoid confounding?Nephron Clin Pract. 2011;118(4):c315-c318.
van Stralen KJ, Jager KJ, Verrina E, Schaefer FS, Emma F.Suggested revision of the National High Blood Pressure Education Program blood pressure standardization for use in severely growth retarded children.Pediatr Nephrol. 2011 May;26(5):819-820.
Koopman JJ, Rozing MP, Kramer A, De Jager DJ, Ansell D, De Meester JM, Prütz KG, Finne P, Heaf JG, Palsson R, Kramar R, Jager KJ, Dekker FW, Westendorp RG.Senescence rates in patients with end-stage renal disease: a critical appraisal of the Gompertz model.Aging Cell. 2011 Apr;10(2):233-238.
Ravelli ACJ, Jager KJ, de Groot MH, Erwich JJHM, Rijninks-van Driel GC, Tromp M, Eskes M, Abu-Hanna A, Mol BWJ.Travel time from home to hospital and adverse perinatal outcomes in women at term in the Netherlands.BJOG. 2011 Mar;118(4):457-465.
Süleymanlar G, Serdengeçti K, Altiparmak MR, Jager K, Seyahi N, Erek E; Turkish Registry of Nephrology, Dialysis, and Transplantation.Trends in renal replacement therapy in Turkey, 1996-2008.Am J Kidney Dis. 2011 Mar;57(3):456-465.
Stel VS, van de Luijtgaarden MW, Wanner C, Jager KJ; on behalf of the European Renal Registry Investigators.The 2008 ERA-EDTA Registry Annual Report-a précis.NDT Plus. Feb;4(1):1-13.
Carrero JJ, de Mutsert R, Axelsson J, Dekkers OM, Jager KJ, Boeschoten EW, Krediet RT, Dekker FW; for the NECOSAD Study Group.Sex differences in the impact of diabetes on mortality in chronic dialysis patients.Nephrol Dial Transplant. 2011 Jan;26(1):270-276.
Verduijn M, Grootendorst DC, Dekker FW, Jager KJ, le Cessie S.The analysis of competing events like cause-specific mortality–beware of the Kaplan-Meier method.Nephrol Dial Transplant. 2011 Jan;26(1):56-61.
Stel VS, Jager KJ.Glomerular filtration rate and initiation of dialysis.CMAJ. 2011 Jan 11;183(1):24-25.
2010
Zoccali C, Jager KJ.Risk factors: hyperhomocysteinemia: a renal and cardiovascular risk factor?Nat Rev Nephrol. 2010 Dec;6(12):695-696.
Jager KJ, Stel VS, Zoccali C, Wanner C, Dekker FW.The issue of studying the effect of interventions in renal replacement therapy — to what extent may we be deceived by selection and competing risk?Nephrol Dial Transplant. 2010 Dec;25(12):3836-3839.
van den Beukel TO, Jager KJ, Siegert CE, Schoones JW, Dekker FW.Racial minority groups on dialysis in Europe: a literature review.Clin Nephrol. 2010 Nov;74 Suppl 1):78-84.
Tripepi G, Jager KJ, Dekker FW, Zoccali C.Stratification for confounding – part 2: direct and indirect standardization.Nephron Clin Pract. 2010;116(4):c322-c325.
Tripepi G, Jager KJ, Dekker FW, Zoccali C.Stratification for confounding – part 1: the Mantel-Haenszel formula.Nephron Clin Pract. 2010;116(4)::c317-c321.
van Stralen KJ, Dekker FW, Zoccali C, Jager KJ.Confounding.Nephron Clin Pract. 2010;116(2):c143-c147.
Stel VS, Tomson C, Ansell D, Casino FG, Collart F, Finne P, Ioannidis GA, De Meester J, Salomone M, Traynor JP, Zurriaga O, Jager KJ.Level of renal function in patients starting dialysis: an ERA-EDTA Registry study.Nephrol Dial Transplant. 2010 Oct;25(10):3315-3325.
van Stralen KJ, Tizard EJ, Jager KJ, Schaefer F, Vondrak K, Groothoff JW, Podracká L, Holmberg C, Jankauskiené A, Lewis MA, van Damme-Lombaerts R, Mota C, Niaudet P, Novljan G, Peco-Antic A, Sahpazova E, Toots U, Verrina E.Determinants of eGFR at start of renal replacement therapy in paediatric patients.Nephrol Dial Transplant. 2010 Oct;25(10):3325-3332.
Tsakiris DJ, Simpson K, Stel V, Wanner C, Jager KJ.Disease classification: a pitfall of the ERA/EDTA registry?Nephrol Dial Transplant. 2010 Aug;25(8):2799.
van Stralen KJ, Tizard EJ, Verrina E, Schaefer F, Jager KJ; on behalf of the European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplant Association (ESPN/ERA-EDTA) registry study group.Demographics of paediatric renal replacement therapy in Europe: 2007 annual report of the ESPN/ERA-EDTA registry.Pediatr Nephrol. 2010 Jul;25(7):1379-1382.
de Vos MLG, van der Veer SN, Graafmans WC, de Keizer NF, Jager KJ, Westert GP, van der Voort PHJ. Implementing quality indicators in intensive care units: exploring barriers to and facilitators of behaviour change.Implement Sci. 2010 Jul 1;5:52.
Tripepi G, Jager KJ, Dekker FW, Zoccali C.Selection bias and information bias in clinical research.Nephron Clin Pract. 2010;115(2):c94-c99.
Tripepi G, Jager KJ, Dekker FW, Zoccali C.Measures of effect in epidemiological research.Nephron Clin Pract. 2010;115(2):c91-c93.
Noordzij M, Dekker FW, Zoccali C, Jager KJ.Measures of disease frequency: prevalence and incidence.Nephron Clin Pract. 2010;115(1):c17-c20.
Zoccali C, Kramer A, Jager KJ.Epidemiology of CKD in Europe: an uncertain scenario.Nephrol Dial Transplant. 2010 Jun;25(6):1731-1733.
Zoccali C, Kramer A, Jager KJ.Chronic kidney disease and end-stage renal disease-a review produced to contribute to the report ‘the status of health in the European union: towards a healthier Europe’NDT Plus 2010 Jun;3(3):213-224.
Tripepi G, Jager KJ, Dekker FW, Zoccali C.Statistical methods for the assessment of prognostic biomarkers(part II): calibration and re-classification.Nephrol Dial Transplant. 2010 May;25(5):1402-1405.
Tripepi G, Jager KJ, Dekker FW, Zoccali C.Statistical methods for the assessment of prognostic biomarkers (Part I): discrimination.Nephrol Dial Transplant. 2010 May;25(5):1399-1401.
Verduijn M, Siegerink B, Jager KJ, Zoccali C, Dekker FW.Mendelian randomization: use of genetics to enable causal inference in observational studies.Nephrol Dial Transplant. 2010 May;25(5):1394-1398.
Noordzij M, Tripepi G, Dekker FW, Zoccali C, Tanck MW, Jager KJ.Sample size calculations: basic principles and common pitfalls.Nephrol Dial Transplant. 2010 May;25(5):1388-1393.
Tsakiris DJ, Stel VS, Finne P, Fraser E, Heaf J, de Meester J, Schmaldienst S, Dekker F, Verrina E, Jager KJ.Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.Nephrol Dial Transplant. 2010 Apr;25(4):1200-1206.
Grootendorst DC, Jager KJ, Zoccali C, Dekker FW.Observational studies are complementary to randomized controlled trials.Nephron Clin Pract. 2010;114(3):c173-c177.
van Stralen KJ, Dekker FW, Zoccali C, Jager KJ.Case-control studies–an efficient observational study design.Nephron Clin Pract. 2010;114(1):c1-4.
Caskey FJ, Stel VS, Elliott RF, Jager KJ, Covic A, Cusumano A, Geue C, Kramer A, Stengel B, MacLeod AM.The EVEREST study: an international collaboration.NDT Plus. 2010 Feb;3(1):28-36.
2009
Zoccali C, Kramer A, Jager K.The databases: renal replacement therapy since 1989–the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA).Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S18-522.
Stel VS, Kramer A, Zoccali C, Jager KJ.The 2007 ERA-EDTA Registry annual report-a précis.NDT Plus. 2009 Dec;2(6):514-521.
Kramer A, Stel V, Zoccali C, Heaf J, Ansell D, Grönhagen-Riska C, Leivestad T, Simpson K, Pálsson R, Postorino M, Jager K; ERA-EDTA Registry.An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.Nephrol Dial Transplant. 2009 Dec;24(12):3557-3566.
Noordzij M, Hooft L, Dekker FW, Zoccali C, Jager KJ.Systematic reviews and meta-analyses: when they are useful and when to be careful.Kidney Int.2009 Dec;76(11):1130-1136.
Visser A, Dijkstra GJ, Kuiper D, de Jong PE, Franssen CFM, Gansevoort RT, Izaks GJ, Jager KJ, Reijneveld SA. Accepting or declining dialysis: considerations taken into account by elderly patients with end-stage renal diseaseJ Nephrol. Nov-Dec 2009;22(6):794-799.
de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, Wetzels JF, Rosendaal FR, Dekker FW.Cardiovascular and noncardiovascular mortality among patients starting dialysis.JAMA. 2009 Oct 28;302(16):1782-1789.
Stel VS, Dekker FW, Ansell D, Augustijn H, Casino FG, Collart F, Finne P, Ioannidis GA, Salomone M, Traynor JP, Zurriaga O, Verrina E, Jager KJ.Residual renal function at the start of dialysis and clinical outcomes.Nephrol Dial Transplant. 2009 Oct;24(10):3175-3182
Grootendorst DC, Jager KJ, Zoccali K, Dekker FW. Screening: why, when, and how.Kidney Int. 2009 Oct;76(7):694-699
Stel VS, Zoccali C, Dekker FW, Jager KJ.The randomized controlled trial.Nephron Clin Pract. 2009;113(4):c337-c342.
Tizard EJ, Verrina E, van Stralen KJ, Jager KJ.Progress with the European Society for Paediatric Nephrology (ESPN)/ERA-EDTA Registry for children with established renal failure (ERF).Nephrol Dial Transplant. 2009 Sep;24(9):2615-2617.
Euser AM, Zoccali C, Jager KJ, Dekker FW.Cohort studies: prospective versus retrospective.Nephron Clin Pract. 2009;113(3):c214-c217.
Noordzij M, Dekker FW, Zoccali C, Jager KJ.Study designs in clinical research.Nephron Clin Pract. 2009;113(3):c218-c221.
Jager KJ, Zoccali C.Comorbidity data collection by renal registries–a remaining challenge.Nephrol Dial Transplant. 2009 Aug;24(8):2311-2313.
Tripepi G, Jager KJ, Dekker FW, Zoccali C.Diagnostic methods 2: receiver operating characteristic (ROC) curves.Kidney Int.2009 Aug;76(3):252-256.
van Stralen KJ, Stel VS, Reitsma JB, Dekker FW, Zoccali C, Jager KJ.Diagnostic methods I: sensitivity, specificity, and other measures of accuracy.Kidney Int. 2009 Jun;75(12):1257-1263.
de Mutsert R, Jager KJ, Zoccali C, Dekker FW.The effect of joint exposures: examining the presence of interaction.Kidney Int. 2009 Apr;75(7):677-681.
Couchoud C, Jager KJ, Tomson C, Cabanne JF, Collart F, Finne P, de Francisco A, Frimat L, Garneata L, Leivestad T, Lemaitre V, Limido A, Ots M, Resic H, Stojceva-Taneva O, Kooman J; On behalf of the QUEST working group on dialysis adequacy.Assessment of urea removal in haemodialysis and the impact of the European best practice guidelines.Nephrol Dial Transplant.2009 Apr;24(4):1267-1274
Kramer A, Stel VS, Tizard J, Verrina E, Rönnholm K, Pálsson R, Maxwell H, Jager KJ.Characteristics and survival of young adults who started renal replacement therapy during childhood.Nephrol Dial Transplant.2009 Mar;24(3):926-933.
Stel VS, Kramer A, Zoccali C, Jager KJ.The 2006 ERA-EDTA Registry annual report: a précis.J Nephrol. Jan-Feb 2009;22(1):1-12.
Couchoud C, Kooman J, Finne P, Leivestad T, Stojceva-Taneva O, Ponikvar JB, Collart F, Kramar R, de Francisco A, Jager KJ; QUality European STudies Working Group on Dialysis Adequacy.From registry data collection to international comparisons: examples of haemodialysis duration and frequency.Nephrol Dial Transplant. 2009 Jan;24(1):217-224.
2008
Tripepi G, Jager KJ, Dekker FW, Zoccali C.Testing for causality and prognosis: etiological and prognostic models.Kidney Int. 2008 Dec;74(12):1512-1515.
Jager KJ and Zoccali C.What’s new at the ERA-EDTA Registry?Port J Nephrol Hypert. 2008;22 (2):139-141.
van Stralen KJ, Jager KJ, Zoccali C, Dekker FW.Agreement between methods.Kidney Int. 2008 Nov;74(9):1116-1120.
Dekker FW, de Mutsert R, van Dijk PC, Zoccali C, Jager KJ.Survival analysis: time-dependent effects and time-varying risk factors.Kidney Int. 2008 Oct;74(8):994-997.
van Dijk PC, Jager KJ, Zwinderman AH, Zoccali C, Dekker FW.The analysis of survival data in nephrology: basic concepts and methods of Cox regression.Kidney Int. 2008 Sep;74(6):705-709.
Jager KJ, van Dijk PC, Zoccali C, Dekker FW.The analysis of survival data: The Kaplan-Meier method.Kidney Int. 2008 Sep;74(5):560-565.
Tripepi G, Jager KJ, Dekker FW, Zoccali C.Linear and logistic regression analysis.Kidney Int. 2008 Apr;73(7):806-810.
Jager KJ, Zoccali C.Quality of care in end-stage renal disease: the importance of comparing ‘apples with apples’.Nephrol Dial Transplant. 2008 Apr;23(4):1116.
Jager KJ, Zoccali C, Macleod A, Dekker FW.Confounding: what it is and how to deal with it.Kidney Int. 2008 Feb;73(3):256-260.
Tripepi G, Jager KJ, Dekker FW, Wanner C, Zoccali C.Bias in clinical research.Kidney Int. 2008 Jan;73(2):148-153.
2007
Stewart JH, McCredie MR, Williams SM, Jager KJ, Trpeski L, McDonald SP; ESRD Incidence Study Group.Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.Nephrology (Carlton). 2007 Oct;12(5):520-527.
Tripepi G, Jager KJ, Dekker FW, Wanner C, Zoccali C.Measures of effect: Relative risks, odds ratios, risk difference, and ‘number needed to treat’.Kidney Int. 2007 Oct;72(7):789-791.
Del Vecchio L, Locatelli F, Martins Prata M, Wauters JP, Debska-Slizien A, Mauri JM, Metsärinne K, Mircescu G, Siamopoulos KC, Stel VS, Will E, Van Biesen W, Jager KJ, Zoccali C; QUEST Anemia Study Group.The QUEST initiative anemia study in ESRD: rationale and study protocol.J Nephrol. Sep-Oct 2007;20(5):547-553.
Van Biesen W, Locatelli F, Martins Prata M, Wauters JP, Debska-Slizien A, Mauri JM, Metsärinne K, Mircescu G, Siamopoulos KC, Stel VS, Will E, Del Vecchio L, Zoccali C, Jager KJ; QUEST Anemia Study Group.The QUEST initiative anemia study in transplant patients: rationale and study protocol.J Nephrol. Sep-Oct 2007;20(5):543-546.
Stel VS, Jager KJ, Zoccali C, Wanner C, Dekker FW.The randomized clinical trial: An unbeatable standard in clinical research?Kidney Int. 2007 Sep;72(5):539-542.
Jager KJ, Stel VS, Wanner C, Zoccali C, Dekker FW.The valuable contribution of observational studies to nephrology.Kidney Int. 2007 Sep;72(6):671-675.
Jager KJ, Zoccali C, Kramar R, Dekker FW.Measuring disease occurrence.Kidney Int. 2007 Aug;72(4):412-415.
Jager KJ, Zoccali C.Clinical Databases and the QUEST Initiative.Blood Purif. 2007;25(3):219-220.
Jager KJ, van Dijk PC.Has the rise in the incidence of renal replacement therapy in developed countries come to an end?Nephrol Dial Transplant.2007 Mar;22(3):678-680.
van Dijk PCW, Zwinderman AH, Dekker FW, Schön S, Stel VS, Finne P, Jager KJ.Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe.Kidney Int. 2007 Jan;71(1):53-59.
van Manen JG, van Dijk PCW, Stel VS, Dekker FW, Clèries M, Conte F, Feest T, Kramar R, Leivestad T, Briggs JD, Stengel B, Jager KJ.Confounding effect of comorbidity in survival studies in patients on renal replacement therapy.Nephrol Dial Transplant.2007 Jan;22(1):187-195.
2006
Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL, Port FK, Jager KJ, Homel P, Augustijn H, de Charro FT, Collart F, Erek E, Finne P, Garcia-Garcia G, Grönhagen-Riska C, Ioannidis GA, Ivis F, Leivestad T, Løkkegaard H, Lopot F, Jin DC,International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality.J Am Soc Nephrol. 2006 Dec;17(12):3510-3519.
The ESRD Incidence Study Group: Stewart JH, McCredie MRE, Williams SM, Trpeski L, Fenton SS, McDonald SP, Jager KJ, van Dijk PCW, Finne P, Schon S, Leivestad T, Løkkegaard H, Billiouw JM, Kramar R, Magaz A, Vela E.Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.Diabet Med. 2006 Dec;23(12):1364-1369.
The ESRD Incidence Study Group: Stewart JH, McCredie MRE, Williams SM, Fenton SS, Trpeski L, McDonald SP, Jager KJ, van Dijk PCW, Finne P, Schon S, Leivestad T, Løkkegaard H, Billiouw JM, Kramar R, Magaz A, Vela E, Garcia-Blasco MJ, Ioannidis GA, LimThe enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002.Am J Kidney Dis. 2006 Aug;48(2):183-191.
The ESRD Incidence Study Group: Stewart JH, McCredie MRE, Williams SM, Fenton SS, Trpeski L, McDonald SP, Jager KJ, van Dijk PCW, Finne P, Schon S, Leivestad T, Løkkegaard H, Billiouw JM, Kramar R, Magaz A, Cleries M, Garcia-Blasco MJ, Ioannidis GA,Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.Nephrol Dial Transplant. 2006 Aug;21(8):2178-2183.
Geddes CC, van Dijk PCW, McArthur S, Metcalfe W, Jager KJ, Zwinderman AH, Mooney M, Fox JG, Simpson K.The ERA-EDTA cohort study–comparison of methods to predict survival on renal replacement therapy.Nephrol Dial Transplant. 2006 Apr;21(4):945-956.
up to and including 2005
Lameire N, Jager KJ, Van Biesen W, de Bacquer D, Vanholder R.Chronic kidney disease: A European perspective.Kidney Int. 2005 Dec;(99):S30-S38.
Stel VS, van Dijk PCW, van Manen JG, Dekker FW, Ansell D, Conte F, Kramar R, Leivestad T, Vela E, Briggs JD, Jager KJ.Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation.Nephrol Dial Transplant. 2005 Dec;20(12):2803-2811.
Jager KJ, Zoccali C.QUality European STudies (QUEST) – a step forward in the quality of RRT care.Nephrol Dial Transplant. 2005 Sep;20(9):2005-2006.
van Dijk PCW, Jager KJ, Stengel B, Grönhagen-Riska C, Feest TG, Briggs JD.Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000).Kidney Int. 2005 Apr;67(4):1489-1499.
van der Heijden BJ, van Dijk PCW, Verrier-Jones K, Jager KJ, Briggs JD.Renal replacement therapy in children: data from 12 registries in Europe.Pediatr Nephrol. 2004 Feb;19(2):213-221.
Jager KJ, van Dijk PCW, Dekker FW, Stengel B, Simpson K, Briggs JD.The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomesClin Nephrol. 2003 Nov;60(5):352-360.
Stengel B, Billon S, van Dijk PCW, Jager KJ, Dekker FW, Simpson K, Briggs JD.Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999.Nephrol Dial Transplant. 2003 Sep;18(9):1824-1833.
Saran R, Bragg-Gresham JL, Rayner HC, Goodkin DA, Keen ML, van Dijk PC, Kurokawa K, Piera L, Saito A, Fukuhara S, Young EW, Held PJ, Port FK. Nonadherence in hemodialysis: Associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int. 2003 Jul;64(1):254-62.
Briggs JD, Jager K.The first year of the new ERA-EDTA registry.Nephrol Dial Transplant. 2001 Jun;16(6):1130-1131.
van Dijk PCW, Jager KJ, de Charro F, Collart F, Cornet R, Dekker FW, Grönhagen-Riska C, Kramar R, Leivestad T, Simpson K, Briggs JD.Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries.Nephrol Dial Transplant. 2001 Jun;16(6):1120-1129.
Jager KJ, van Dijk PCW, Dekker FW, Cornet R, Krediet RT, Briggs JD.The European registry: where do we stand?Perit Dial Int. 2000;20 Suppl 2:S118-120.
